,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af
0,1,M,V,,,,,,,,,,s,"IAP-binding motif (IBM), 1-5, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1,2,A,E,,,,,,,,,,s,"IAP-binding motif (IBM), 1-5, ELM",,COSMIC,,,"hg38,16:3717504-3717504","hg38,16:g.3717504G>T",0.142,lung,"carcinoma, adenocarcinoma",,
2,2,A,S,,,,,,,,,,s,"IAP-binding motif (IBM), 1-5, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,16:3717505-3717505","hg38,16:g.3717505C>A",0.112,"skin, head_neck",malignant_melanoma,0.0004268511861970,0.0001619170984456
3,3,R,,,,,,,,,,,s,"IAP-binding motif (IBM), 1-5, ELM",,,,,,,,,,,
4,4,E,,,,,,,,,,,s,"IAP-binding motif (IBM), 1-5, ELM|Nuclear receptor box, 4-10, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 4-9, ELM",,,,,,,,,,,
5,5,L,M,,,,,,,,,,s,"IAP-binding motif (IBM), 1-5, ELM|Nuclear receptor box, 4-10, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 4-9, ELM",,COSMIC,,,"hg38,16:3717496-3717496","hg38,16:g.3717496G>T",0.094,lung,"carcinoma, adenocarcinoma",,
6,6,R,,,,,,,,,,,s,"PCSK cleavage site, 6-10, ELM|Nuclear receptor box, 4-10, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 4-9, ELM",,,,,,,,,,,
7,7,A,,,,,,,,,,,s,"PCSK cleavage site, 6-10, ELM|Nuclear receptor box, 4-10, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 4-9, ELM",,,,,,,,,,,
8,8,L,,,,,,,,,,,s,"PCSK cleavage site, 6-10, ELM|Nuclear receptor box, 4-10, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 4-9, ELM",,,,,,,,,,,
9,9,L,,,,,,,,,,,s,"PCSK cleavage site, 6-10, ELM|Nuclear receptor box, 4-10, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 4-9, ELM",,,,,,,,,,,
10,10,L,P,,,,,,,,,,s,"PCSK cleavage site, 6-10, ELM|Nuclear receptor box, 4-10, ELM",,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,16:3767481-3767481","hg19,16:g.3767481A>G",0.136,,,,
11,11,W,C,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3767477-3767477","hg19,16:g.3767477C>A",0.212,,,,
12,12,G,,,,,,,,,,,s,,,,,,,,,,,,
13,13,R,C,,,,,,,,,,s,"NRD cleavage site, 13-15, ELM|di Arginine retention/retrieving signal, 13-16, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",all_phase2_target_2018_pub,B-Lymphoblastic Leukemia/Lymphoma,"hg19,16:3767473-3767473, hg38,16:3717472-3717472","hg19,16:g.3767473G>A, hg38,16:g.3717472G>A",0.020,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, acute_lymphoblastic_leukaemia",0.0789969273466151,0.0598376623376623
14,14,R,,,,,,,,,,,s,"NRD cleavage site, 13-15, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 14-19, ELM|di Arginine retention/retrieving signal, 13-16, ELM|di Arginine retention/retrieving signal, 14-17, ELM",,,,,,,,,,,
15,15,L,,,,,,,,,,,s,"NRD cleavage site, 13-15, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 14-19, ELM|di Arginine retention/retrieving signal, 13-16, ELM|di Arginine retention/retrieving signal, 14-17, ELM",,,,,,,,,,,
16,16,R,,,,,,,,,,,s,"PCSK cleavage site, 16-20, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 14-19, ELM|di Arginine retention/retrieving signal, 13-16, ELM|di Arginine retention/retrieving signal, 14-17, ELM",,,,,,,,,,,
17,17,P,,,,,,,,,,,s,"PCSK cleavage site, 16-20, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 14-19, ELM|di Arginine retention/retrieving signal, 14-17, ELM",,,,,,,,,,,
18,18,L,,,,,,,,,,,s,"PCSK cleavage site, 16-20, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 14-19, ELM",,,,,,,,,,,
19,19,L,,,,,,,,,,,s,"PCSK cleavage site, 16-20, ELM|Calcineurin (PP2B)-docking motif LxvP, 19-22, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 14-19, ELM",,,,,,,,,,,
20,20,R,,,,,,,,,,,s,"PCSK cleavage site, 16-20, ELM|Calcineurin (PP2B)-docking motif LxvP, 19-22, ELM",,,,,,,,,,,
21,21,A,V,,,,,,,,,,s,"Calcineurin (PP2B)-docking motif LxvP, 19-22, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,16:3767448-3767448","hg19,16:g.3767448G>A",0.017,,,,0.0000324359390204
22,22,P,,,,,,,,,,,s,"MAPK docking motifs, 22-38, ELM|Calcineurin (PP2B)-docking motif LxvP, 19-22, ELM",,,,,,,,,,,
23,23,A,,,,,,,,,,,s,"MAPK docking motifs, 22-38, ELM",,,,,,,,,,,
24,24,L,,,,,,,,,,,s,"MAPK docking motifs, 22-38, ELM",,,,,,,,,,,
25,25,A,,,,,,,,,,,s,"MAPK docking motifs, 22-38, ELM",,,,,,,,,,,
26,26,A,,,,,,,,,,,s,"MAPK docking motifs, 22-38, ELM",,,,,,,,,,,
27,27,V,,,,,,,,,,,s,"MAPK docking motifs, 22-38, ELM",,,,,,,,,,,
28,28,P,,,,,,,,,,,s,"MAPK docking motifs, 22-38, ELM",,,,,,,,,,,
29,29,G,,,,,,,,,,,s,"MAPK docking motifs, 22-38, ELM",,,,,,,,,,,
30,30,G,,,,,,,,,,,s,"MAPK docking motifs, 22-38, ELM",,,,,,,,,,,
31,31,K,,,,,,,,,,,s,"PCSK cleavage site, 31-35, ELM|MAPK docking motifs, 22-38, ELM",,,,,,,,,,,
32,32,P,L,,,,,,,,,,s,"PCSK cleavage site, 31-35, ELM|MAPK docking motifs, 22-38, ELM|MAPK docking motifs, 32-47, ELM|MYND domain binding motif., 32-36, ELM",,COSMIC,,,"hg38,16:3690979-3690979","hg38,16:g.3690979G>A",0.034,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,
33,32,P,Q,,,,,,,,,,s,"PCSK cleavage site, 31-35, ELM|MAPK docking motifs, 22-38, ELM|MAPK docking motifs, 32-47, ELM|MYND domain binding motif., 32-36, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:3740980-3740980, hg38,16:3690979-3690979","hg19,16:g.3740980G>T, hg38,16:g.3690979G>T",0.025,skin,malignant_melanoma,,
34,33,I,,,,,,,,,,,s,"PCSK cleavage site, 31-35, ELM|MAPK docking motifs, 22-38, ELM|MAPK docking motifs, 32-47, ELM|MYND domain binding motif., 32-36, ELM",,,,,,,,,,,
35,34,L,,,,,,,,,,,s,"PCSK cleavage site, 31-35, ELM|MAPK docking motifs, 22-38, ELM|MAPK docking motifs, 32-47, ELM|MYND domain binding motif., 32-36, ELM",,,,,,,,,,,
36,35,C,,,,,,,,,,,s,"PCSK cleavage site, 31-35, ELM|MAPK docking motifs, 22-38, ELM|MAPK docking motifs, 32-47, ELM|MYND domain binding motif., 32-36, ELM",,,,,,,,,,,
37,36,P,L,,,,,,,,,,s,"MAPK docking motifs, 22-38, ELM|MAPK docking motifs, 32-47, ELM|MYND domain binding motif., 32-36, ELM|di Arginine retention/retrieving signal, 36-38, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,16:3740968-3740968, hg38,16:3690967-3690967","hg19,16:g.3740968G>A, hg38,16:g.3690967G>A",0.049,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
38,37,R,W,,,,,,,,,,s,"NRD cleavage site, 37-39, ELM|MAPK docking motifs, 22-38, ELM|MAPK docking motifs, 32-47, ELM|14-3-3 binding phosphopeptide motif, 37-45, ELM|di Arginine retention/retrieving signal, 36-38, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","cscc_hgsc_bcm_2014, metastatic_solid_tumors_mich_2017","Cutaneous Squamous Cell Carcinoma, Mixed Cancer Types","hg19,16:3740966-3740966, hg38,16:3690965-3690965","hg19,16:g.3740966G>A, hg38,16:g.3690965G>A",0.036,"skin, head_neck","carcinoma, squamous_cell_carcinoma",0.0000904111046110,0.0000955414012739
39,38,R,M,,,,,,,,,,s,"NRD cleavage site, 37-39, ELM|MAPK docking motifs, 22-38, ELM|MAPK docking motifs, 32-47, ELM|14-3-3 binding phosphopeptide motif, 37-45, ELM|14-3-3 binding phosphopeptide motif, 38-45, ELM|FHA phosphopeptide ligands, 38-44, ELM|di Arginine retention/retrieving signal, 36-38, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3740962-3740962","hg19,16:g.3740962C>A",0.136,,,,
40,39,T,I,P,,,,,,,,,s,"NRD cleavage site, 37-39, ELM|MAPK docking motifs, 32-47, ELM|14-3-3 binding phosphopeptide motif, 37-45, ELM|14-3-3 binding phosphopeptide motif, 38-45, ELM|FHA phosphopeptide ligands, 38-44, ELM",,cBioPortal,"mixed_allen_2018, skcm_mskcc_2014","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:3740959-3740959","hg19,16:g.3740959G>A",0.066,,,,
41,40,T,,P,,,,,,,,,s,"MAPK docking motifs, 32-47, ELM|14-3-3 binding phosphopeptide motif, 37-45, ELM|14-3-3 binding phosphopeptide motif, 38-45, ELM|FHA phosphopeptide ligands, 38-44, ELM",,,,,,,,,,,
42,41,A,S,,,,,,,,,,s,"MAPK docking motifs, 32-47, ELM|14-3-3 binding phosphopeptide motif, 37-45, ELM|14-3-3 binding phosphopeptide motif, 38-45, ELM|FHA phosphopeptide ligands, 38-44, ELM",,cBioPortal,"paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,16:3740954-3740954","hg19,16:g.3740954C>A",0.066,,,,
43,41,A,V,,,,,,,,,,s,"MAPK docking motifs, 32-47, ELM|14-3-3 binding phosphopeptide motif, 37-45, ELM|14-3-3 binding phosphopeptide motif, 38-45, ELM|FHA phosphopeptide ligands, 38-44, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:3740953-3740953, hg38,16:3690952-3690952","hg19,16:g.3740953G>A, hg38,16:g.3690952G>A",0.030,skin,malignant_melanoma,0.0000093751464867,
44,42,Q,,,,,,,,,,,s,"MAPK docking motifs, 32-47, ELM|14-3-3 binding phosphopeptide motif, 37-45, ELM|14-3-3 binding phosphopeptide motif, 38-45, ELM|FHA phosphopeptide ligands, 38-44, ELM",,,,,,,,,,,
45,43,L,,,,,,,,,,,s,"MAPK docking motifs, 32-47, ELM|14-3-3 binding phosphopeptide motif, 37-45, ELM|14-3-3 binding phosphopeptide motif, 38-45, ELM|FHA phosphopeptide ligands, 38-44, ELM",,,,,,,,,,,
46,44,G,,,,,,,,,,,s,"MAPK docking motifs, 32-47, ELM|14-3-3 binding phosphopeptide motif, 37-45, ELM|14-3-3 binding phosphopeptide motif, 38-45, ELM|FHA phosphopeptide ligands, 38-44, ELM",,,,,,,,,,,
47,45,P,,,,,,,,,,,s,"MAPK docking motifs, 32-47, ELM|14-3-3 binding phosphopeptide motif, 37-45, ELM|14-3-3 binding phosphopeptide motif, 38-45, ELM|di Arginine retention/retrieving signal, 45-47, ELM",,,,,,,,,,,
48,46,R,,,,,,,,,,,s,"NRD cleavage site, 46-48, ELM|MAPK docking motifs, 32-47, ELM|di Arginine retention/retrieving signal, 45-47, ELM",,,,,,,,,,,
49,47,R,Q,,,,,,,,,,s,"NRD cleavage site, 46-48, ELM|MAPK docking motifs, 32-47, ELM|di Arginine retention/retrieving signal, 45-47, ELM",,"cBioPortal,COSMIC",brca_tcga_pan_can_atlas_2018,Invasive Breast Carcinoma,"hg19,16:3740935-3740935, hg38,16:3690934-3690934","hg19,16:g.3740935C>T, hg38,16:g.3690934C>T",0.040,breast,carcinoma,0.0000481101459924,0.0001273723092600
50,48,N,,,,,,,,,,,s,"NRD cleavage site, 46-48, ELM",,,,,,,,,,,
51,49,P,,,,,,,,,,,s,,,,,,,,,,,,
52,50,A,,,,,,,,,,,s,,,,,,,,,,,,
53,51,W,,,,,,,,,,,s,,,,,,,,,,,,
54,52,S,I,,,,,,,,,,s,,,"cBioPortal,COSMIC",stad_tcga_pub,Stomach Adenocarcinoma,"hg19,16:3740920-3740920, hg38,16:3690919-3690919","hg19,16:g.3740920C>A, hg38,16:g.3690919C>A",0.046,stomach,"carcinoma, adenocarcinoma",,
55,53,L,,,,,,,,,,,s,,,,,,,,,,,,
56,54,Q,,,,,,,,,,,s,,,,,,,,,,,,
57,55,A,V,,,,,,,,,,s,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,16:3740911-3740911, hg38,16:3690910-3690910","hg19,16:g.3740911G>A, hg38,16:g.3690910G>A",0.032,"large_intestine, colon, right","carcinoma, adenocarcinoma",0.0000427869722227,0.0000318390219052
58,56,G,,,,,,,,,,,s,,,,,,,,,,,,
59,57,R,Q,,,,,,,,,,s,,,cBioPortal,gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,16:3740905-3740905","hg19,16:g.3740905C>T",0.015,,,0.0000213252354306,0.0000318410494810
60,58,L,,,,,,,,,,,s,,,,,,,,,,,,
61,59,F,,,,,,,,,,,s,,,,,,,,,,,,
62,60,S,G,,,,,,,,,,D,,,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:3740897-3740897, hg38,16:3690896-3690896","hg19,16:g.3740897T>C, hg38,16:g.3690896T>C",0.168,endometrium,"carcinoma, endometrioid_carcinoma",,
63,60,S,N,,,,,,,,,,D,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3740896-3740896","hg19,16:g.3740896C>T",0.158,,,,
64,61,T,,,,,,,,,,,D,"FHA phosphopeptide ligands, 61-67, ELM",,,,,,,,,,,
65,62,Q,,,,,,,,,,,D,"FHA phosphopeptide ligands, 61-67, ELM",,,,,,,,,,,
66,63,T,,,,,,,,,,,D,"FHA phosphopeptide ligands, 61-67, ELM",,,,,,,,,,,
67,64,A,,,,,,,,,,,D,"FHA phosphopeptide ligands, 61-67, ELM",,,,,,,,,,,
68,65,E,K,,,,,,,,,,D,"FHA phosphopeptide ligands, 61-67, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Colorectal Adenocarcinoma, Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:3740882-3740882, hg38,16:3690881-3690881","hg19,16:g.3740882C>T, hg38,16:g.3690881C>T",0.147,"large_intestine, lung","carcinoma, adenocarcinoma",0.0000217225079939,
69,66,D,,,,,,,,,,,D,"FHA phosphopeptide ligands, 61-67, ELM",,,,,,,,,,,
70,67,K,,,,,,,,,,,D,"FHA phosphopeptide ligands, 61-67, ELM",,,,,,,,,,,
71,68,E,D,,,,,,,,,,D,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3740871-3740871","hg19,16:g.3740871C>A",0.284,,,,
72,69,E,,,,,,,,,,,C,,,,,,,,,,,,
73,70,P,T,,,,,,,,,,C,"USP7 binding motif, 70-74, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3740867-3740867","hg19,16:g.3740867G>T",0.058,,,,
74,71,L,,,,,,,,,,,C,"USP7 binding motif, 70-74, ELM",,,,,,,,,,,
75,72,H,,,,,,,,,,,C,"USP7 binding motif, 70-74, ELM",,,,,,,,,,,
76,73,S,L,,,,,,,,,,C,"USP7 binding motif, 70-74, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3740857-3740857","hg19,16:g.3740857G>A",0.035,,,0.0000047140904163,
77,74,I,,,,,,,,,,,C,"USP7 binding motif, 70-74, ELM",,,,,,,,,,,
78,75,I,,,,,,,,,,,C,,,,,,,,,,,,
79,76,S,,,,,,,,,,,C,"FHA phosphopeptide ligands, 76-82, ELM",,,,,,,,,,,
80,77,S,N,,,,,,,,,,C,"FHA phosphopeptide ligands, 76-82, ELM",,COSMIC,,,"hg38,16:3690844-3690844","hg38,16:g.3690844C>T",0.059,liver,"carcinoma, combined_hepatocellular-cholangiocarcinoma",,
81,78,T,,,,,,,,,,,C,"FHA phosphopeptide ligands, 76-82, ELM",,,,,,,,,,,
82,79,E,G,,,,,,,,,,C,"FHA phosphopeptide ligands, 76-82, ELM",,COSMIC,,,"hg38,16:3690838-3690838","hg38,16:g.3690838T>C",0.275,endometrium,"carcinoma, endometrioid_carcinoma",0.0000052704810895,
83,80,S,,,,,,,,,,,C,"FHA phosphopeptide ligands, 76-82, ELM",,,,,,,,,,,
84,81,V,,,,,,,,,,,C,"FHA phosphopeptide ligands, 76-82, ELM",,,,,,,,,,,
85,82,Q,,,,,,,,,,,C,"FHA phosphopeptide ligands, 76-82, ELM",,,,,,,,,,,
86,83,G,,,,,,,,,,,C,,,,,,,,,,,,
87,84,S,C,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3739135-3739135","hg19,16:g.3739135G>C",0.143,,,,
88,85,T,,,,,,,,,,,S,,,,,,,,,,,,
89,86,S,F,,,,,,,,,,S,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,16:3739129-3739129, hg38,16:3689128-3689128","hg19,16:g.3739129G>A, hg38,16:g.3689128G>A",0.531,skin,"carcinoma, basal_cell_carcinoma",0.0000079629246230,
90,87,K,,,,,,,,,,,S,,,,,,,,,,,,
91,88,H,N,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3689123-3689123","hg38,16:g.3689123G>T",0.489,liver,"other, neoplasm",,
92,88,H,R,,,,,,,,,,S,,,"cBioPortal,COSMIC",prad_fhcrc,Prostate Adenocarcinoma,"hg19,16:3739123-3739123, hg38,16:3689122-3689122","hg19,16:g.3739123T>C, hg38,16:g.3689122T>C",0.618,prostate,"carcinoma, adenocarcinoma",,
93,89,E,Q,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3689120-3689120","hg38,16:g.3689120C>G",0.403,"urinary_tract, bladder","carcinoma, small_cell_carcinoma",,
94,89,E,V,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3689119-3689119","hg38,16:g.3689119T>A",0.563,"haematopoietic_and_lymphoid_tissue, mediastinum","lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",0.0000802916191608,0.0000636983247341
95,90,F,L,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3689115-3689115","hg38,16:g.3689115G>T",0.835,lung,"carcinoma, adenocarcinoma",,
96,91,Q,,,,,,,,,,,C,,,,,,,,,,,,
97,92,A,,,,,,,,,,,C,"FHA phosphopeptide ligands, 92-98, ELM",,,,,,,,,,,
98,93,E,,,,,,,,,,,C,"FHA phosphopeptide ligands, 92-98, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 93-98, ELM",,,,,,,,,,,
99,94,T,,,,,,,,,,,S,"FHA phosphopeptide ligands, 92-98, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 93-98, ELM",,,,,,,,,,,
100,95,K,,,,,,,,,,,S,"PCSK cleavage site, 95-99, ELM|FHA phosphopeptide ligands, 92-98, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 93-98, ELM",,,,,,,,,,,
101,96,K,,,,,,,Ac,,,,S,"PCSK cleavage site, 95-99, ELM|FHA phosphopeptide ligands, 92-98, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 93-98, ELM",,,,,,,,,,,
102,97,L,,,,,,,,,,,S,"PCSK cleavage site, 95-99, ELM|FHA phosphopeptide ligands, 92-98, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 93-98, ELM",,,,,,,,,,,
103,98,L,,,,,,,,,,,S,"PCSK cleavage site, 95-99, ELM|FHA phosphopeptide ligands, 92-98, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 93-98, ELM",,,,,,,,,,,
104,99,D,Y,,,,,,,,,,C,"PCSK cleavage site, 95-99, ELM",,"cBioPortal,COSMIC",lihc_tcga_pan_can_atlas_2018,Hepatocellular Carcinoma,"hg19,16:3739091-3739091, hg38,16:3689090-3689090","hg19,16:g.3739091C>A, hg38,16:g.3689090C>A",0.627,liver,"carcinoma, hepatocellular_carcinoma",,
105,100,I,F,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3689087-3689087","hg38,16:g.3689087T>A",0.724,"skin, mucosal, nasopharynx",malignant_melanoma,,
106,101,V,,,,,,,,,,,S,,,,,,,,,,,,
107,102,A,,,,,,,,,,,S,,,,,,,,,,,,
108,103,R,W,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 103-113, ELM",,COSMIC,,,"hg38,16:3689078-3689078","hg38,16:g.3689078G>A",0.650,"pancreas, ampulla_of_Vater",carcinoma,0.0000517207081759,0.0001593168493500
109,104,S,F,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 103-113, ELM",,cBioPortal,nsclc_tcga_broad_2016,Non-Small Cell Lung Cancer,"hg19,16:3739075-3739075","hg19,16:g.3739075G>A",0.908,,,,
110,105,L,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 103-113, ELM",,,,,,,,,,,
111,106,Y,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 103-113, ELM",,,,,,,,,,,
112,107,S,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 103-113, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 107-113, ELM",,,,,,,,,,,
113,108,E,K,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 103-113, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 107-113, ELM",,COSMIC,,,"hg38,16:3689063-3689063","hg38,16:g.3689063C>T",0.537,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
114,109,K,,,,Ubq,,,Ac,,,,S,"PCSK cleavage site, 109-113, ELM|14-3-3 binding phosphopeptide motif, 103-113, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 107-113, ELM",,,,,,,,,,,
115,110,E,,,,,,,,,,,S,"PCSK cleavage site, 109-113, ELM|14-3-3 binding phosphopeptide motif, 103-113, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 107-113, ELM",,,,,,,,,,,
116,111,V,,,,,,,,,,,S,"PCSK cleavage site, 109-113, ELM|14-3-3 binding phosphopeptide motif, 103-113, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 107-113, ELM",,,,,,,,,,,
117,112,F,,,,,,,,,,,S,"PCSK cleavage site, 109-113, ELM|14-3-3 binding phosphopeptide motif, 103-113, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 107-113, ELM",,,,,,,,,,,
118,113,I,,,,,,,,,,,S,"PCSK cleavage site, 109-113, ELM|14-3-3 binding phosphopeptide motif, 103-113, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 107-113, ELM",,,,,,,,,,,
119,114,R,L,,,,,,,,,,S,,,cBioPortal,lusc_tcga_pub,Lung Squamous Cell Carcinoma,"hg19,16:3736127-3736127","hg19,16:g.3736127C>A",0.946,,,,
120,114,R,Q,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3736127-3736127","hg19,16:g.3736127C>T",0.936,,,0.0000199049340350,0.0000637104994903
121,114,R,W,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,16:3736128-3736128, hg38,16:3686127-3686127","hg19,16:g.3736128G>A, hg38,16:g.3686127G>A",0.867,stomach,"carcinoma, adenocarcinoma",0.0000238885836459,
122,115,E,,,,,,,,,,,S,,,,,,,,,,,,
123,116,L,,,,,,,,,,,S,,,,,,,,,,,,
124,117,I,,,,,,,,,,,S,,,,,,,,,,,,
125,118,S,,P,,,,,,,,,S,,,,,,,,,,,,
126,119,N,,,,,,,,,,,S,,,,,,,,,,,,
127,120,A,,,,,,,,,,,S,,,,,,,,,,,,
128,121,S,I,P,,,,,,,,,S,,,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:3736106-3736106, hg38,16:3686105-3686105","hg19,16:g.3736106C>A, hg38,16:g.3686105C>A",0.915,endometrium,"carcinoma, endometrioid_carcinoma",,
129,122,D,,,,,,,,,,,S,,,,,,,,,,,,
130,123,A,,,,,,,,,,,S,,,,,,,,,,,,
131,124,L,,,,,,,,,,,S,,,,,,,,,,,,
132,125,E,,,,,,,,,,,S,,,,,,,,,,,,
133,126,K,N,,,,,,Ac,,,,S,"USP7 binding motif, 126-130, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:3736090-3736090, hg38,16:3686089-3686089","hg19,16:g.3736090T>G, hg38,16:g.3686089T>G",0.694,"large_intestine, colon","carcinoma, adenocarcinoma",,
134,127,L,Q,,,,,,,,,,S,"USP7 binding motif, 126-130, ELM",,cBioPortal,prad_p1000,Prostate Adenocarcinoma,"hg19,16:3736088-3736088","hg19,16:g.3736088A>T",0.954,,,,
135,128,R,C,,,,,,,,,,S,"USP7 binding motif, 126-130, ELM",,"cBioPortal,COSMIC",es_dfarber_broad_2014,Ewing Sarcoma,"hg19,16:3736086-3736086, hg38,16:3686085-3686085","hg19,16:g.3736086G>A, hg38,16:g.3686085G>A",0.893,bone,Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour,0.0000278425226917,
136,128,R,H,,,,,,,,,,S,"USP7 binding motif, 126-130, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",sclc_cancercell_gardner_2017,Small Cell Lung Cancer,"hg19,16:3736085-3736085, hg38,16:3686084-3686084","hg19,16:g.3736085C>T, hg38,16:g.3686084C>T",0.890,"large_intestine, large_intestine, colon, transverse, stomach","carcinoma, adenocarcinoma, carcinoma, intestinal_adenocarcinoma",0.0031424275451674,0.0018472514172877
137,129,H,Y,,,,,,,,,,S,"USP7 binding motif, 126-130, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,16:3736083-3736083, hg38,16:3686082-3686082","hg19,16:g.3736083G>A, hg38,16:g.3686082G>A",0.392,"large_intestine, caecum","carcinoma, adenocarcinoma",,
138,130,K,,,,,,,,,,,S,"USP7 binding motif, 126-130, ELM",,,,,,,,,,,
139,131,L,,,,,,,,,,,S,,,,,,,,,,,,
140,132,V,,,,,,,,,,,S,,,,,,,,,,,,
141,133,S,,,,,,,,,,,S,,,,,,,,,,,,
142,134,D,,,,,,,,,,,C,,,,,,,,,,,,
143,135,G,S,,,,,,,,,,S,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,16:3736065-3736065, hg38,16:3686064-3686064","hg19,16:g.3736065C>T, hg38,16:g.3686064C>T",0.309,skin,"carcinoma, basal_cell_carcinoma",0.0000079550064833,
144,136,Q,L,,,,,,,,,,S,,,"cBioPortal,COSMIC",luad_broad,Lung Adenocarcinoma,"hg19,16:3736061-3736061, hg38,16:3686060-3686060","hg19,16:g.3736061T>A, hg38,16:g.3686060T>A",0.336,lung,"carcinoma, adenocarcinoma",,
145,137,A,,,,,,,,,,,S,,,,,,,,,,,,
146,138,L,,,,,,,,,,,S,,,,,,,,,,,,
147,139,P,S,,,,,,,,,,S,,,"cBioPortal,COSMIC",skcm_yale,Cutaneous Melanoma,"hg19,16:3736053-3736053, hg38,16:3686052-3686052","hg19,16:g.3736053G>A, hg38,16:g.3686052G>A",0.273,"skin, acral",malignant_melanoma,,
148,140,E,,,,,,,,,,,S,,,,,,,,,,,,
149,141,M,T,,,,,,,,,,S,,,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3736046-3736046","hg19,16:g.3736046A>G",0.802,,,,
150,142,E,,,,,,,,,,,S,,,,,,,,,,,,
151,143,I,,,,,,,,,,,S,,,,,,,,,,,,
152,144,H,D,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
153,144,H,N,,,,,,,,,,S,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018",Bladder Urothelial Carcinoma,"hg19,16:3736038-3736038, hg38,16:3686037-3686037","hg19,16:g.3736038G>T, hg38,16:g.3686037G>T",0.730,"urinary_tract, bladder",carcinoma,,
154,144,H,R,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3686036-3686036","hg38,16:g.3686036T>C",0.614,"haematopoietic_and_lymphoid_tissue, mediastinum","lymphoid_neoplasm, primary_mediastinal_diffuse_large_B_cell_lymphoma",,
155,145,L,,,,,,,,,,,S,"FHA phosphopeptide ligands, 145-151, ELM",,,,,,,,,,,
156,146,Q,,,,,,,,,,,S,"FHA phosphopeptide ligands, 145-151, ELM",,,,,,,,,,,
157,147,T,,,,,,,,,,,S,"FHA phosphopeptide ligands, 145-151, ELM",,,,,,,,,,,
158,148,N,,,,,,,,,,,S,"FHA phosphopeptide ligands, 145-151, ELM",,,,,,,,,,,
159,149,A,D,,,,,,,,,,S,"FHA phosphopeptide ligands, 145-151, ELM",,COSMIC,,,"hg38,16:3686021-3686021","hg38,16:g.3686021G>T",0.148,liver,"other, neoplasm",,
160,149,A,G,,,,,,,,,,S,"FHA phosphopeptide ligands, 145-151, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
161,150,E,,,,,,,,,,,C,"FHA phosphopeptide ligands, 145-151, ELM",,,,,,,,,,,
162,151,K,,,,,,,,,,,S,"FHA phosphopeptide ligands, 151-157, ELM|FHA phosphopeptide ligands, 145-151, ELM",,,,,,,,,,,
163,152,G,,,,,,,,,,,S,"FHA phosphopeptide ligands, 151-157, ELM|SUMO interaction site, 152-159, ELM",,,,,,,,,,,
164,153,T,,,,,,,,,,,S,"FHA phosphopeptide ligands, 151-157, ELM|FHA phosphopeptide ligands, 153-159, ELM|SUMO interaction site, 152-159, ELM",,,,,,,,,,,
165,154,I,,,,,,,,,,,S,"FHA phosphopeptide ligands, 151-157, ELM|FHA phosphopeptide ligands, 153-159, ELM|SUMO interaction site, 152-159, ELM",,,,,,,,,,,
166,155,T,N,,,,,,,,,,S,"FHA phosphopeptide ligands, 151-157, ELM|FHA phosphopeptide ligands, 153-159, ELM|SUMO interaction site, 152-159, ELM",,COSMIC,,,"hg38,16:3686003-3686003","hg38,16:g.3686003G>T",0.633,liver,"other, neoplasm",,
167,156,I,,,,,,,,,,,S,"FHA phosphopeptide ligands, 151-157, ELM|FHA phosphopeptide ligands, 153-159, ELM|SUMO interaction site, 152-159, ELM",,,,,,,,,,,
168,157,Q,,,,,,,,,,,S,"FHA phosphopeptide ligands, 151-157, ELM|FHA phosphopeptide ligands, 153-159, ELM|SUMO interaction site, 152-159, ELM",,,,,,,,,,,
169,158,D,,,,,,,,,,,S,"FHA phosphopeptide ligands, 153-159, ELM|SUMO interaction site, 152-159, ELM",,,,,,,,,,,
170,159,T,,,,,,,,,,,S,"FHA phosphopeptide ligands, 153-159, ELM|SUMO interaction site, 152-159, ELM",,,,,,,,,,,
171,160,G,D,,,,,,,,,,S,,,cBioPortal,skcm_dfci_2015,Cutaneous Melanoma,"hg19,16:3729784-3729784","hg19,16:g.3729784C>T",0.964,,,,
172,161,I,,,,,,,,,,,S,,,,,,,,,,,,
173,162,G,R,,,,,,,,,,S,"FHA phosphopeptide ligands, 162-168, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3729779-3729779","hg19,16:g.3729779C>T",0.987,,,0.0000119443869344,
174,163,M,,,,,,,,,,,S,"FHA phosphopeptide ligands, 162-168, ELM",,,,,,,,,,,
175,164,T,,,,,,,,,,,S,"FHA phosphopeptide ligands, 162-168, ELM|TRAF2 binding site, 164-167, ELM",,,,,,,,,,,
176,165,Q,,,,,,,,,,,S,"FHA phosphopeptide ligands, 162-168, ELM|TRAF2 binding site, 164-167, ELM",,,,,,,,,,,
177,166,E,,,,,,,,,,,S,"FHA phosphopeptide ligands, 162-168, ELM|TRAF2 binding site, 164-167, ELM",,,,,,,,,,,
178,167,E,K,,,,,,,,,,S,"FHA phosphopeptide ligands, 162-168, ELM|TRAF2 binding site, 164-167, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,16:3729764-3729764, hg38,16:3679763-3679763","hg19,16:g.3729764C>T, hg38,16:g.3679763C>T",0.890,lung,"carcinoma, mixed_adenosquamous_carcinoma",,
179,168,L,,,,,,,,,,,S,"FHA phosphopeptide ligands, 162-168, ELM",,,,,,,,,,,
180,169,V,M,,,,,,,,,,S,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,16:3729758-3729758","hg19,16:g.3729758C>T",0.631,,,,
181,170,S,C,,,,,,,,,,S,,,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,16:3729754-3729754, hg38,16:3679753-3679753","hg19,16:g.3729754G>C, hg38,16:g.3679753G>C",0.814,breast,carcinoma,,
182,170,S,F,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3679753-3679753","hg38,16:g.3679753G>A",0.847,"skin, face",malignant_melanoma,,
183,171,N,S,,,,,,,,,,C,,,cBioPortal,"chol_tcga, chol_tcga_pan_can_atlas_2018",Cholangiocarcinoma,"hg19,16:3729751-3729751","hg19,16:g.3729751T>C",0.710,,,0.0000119379228014,
184,172,L,,,,,,,,,,,C,,,,,,,,,,,,
185,173,G,,,,,,,,,,,C,,,,,,,,,,,,
186,174,T,M,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3729742-3729742","hg19,16:g.3729742G>A",0.928,,,0.0000198974881411,0.0000318654005481
187,175,I,,,,,,,,,,,C,,,,,,,,,,,,
188,176,A,S,,,,,,,,,,C,,,"cBioPortal,COSMIC",sclc_jhu,Small Cell Lung Cancer,"hg19,16:3729737-3729737, hg38,16:3679736-3679736","hg19,16:g.3729737C>A, hg38,16:g.3679736C>A",0.881,lung,"carcinoma, small_cell_carcinoma",0.0000079595654077,
189,177,R,,,,,,,,,,,C,,,,,,,,,,,,
190,178,S,L,,,,,,,,,,C,,,"cBioPortal,COSMIC","metastatic_solid_tumors_mich_2017, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:3729730-3729730, hg38,16:3679729-3679729","hg19,16:g.3729730G>A, hg38,16:g.3679729G>A",0.954,endometrium,"carcinoma, endometrioid_carcinoma",,
191,179,G,,,,,,,,,,,C,"BRCT phosphopeptide ligands, 179-183, ELM",,,,,,,,,,,
192,180,S,,,,,,,,,,,C,"BRCT phosphopeptide ligands, 179-183, ELM",,,,,,,,,,,
193,181,K,,,,,,,,,,,C,"PCSK cleavage site, 181-185, ELM|BRCT phosphopeptide ligands, 179-183, ELM",,,,,,,,,,,
194,182,A,,,,,,,,,,,C,"PCSK cleavage site, 181-185, ELM|BRCT phosphopeptide ligands, 179-183, ELM",,,,,,,,,,,
195,183,F,,,,,,,,,,,C,"PCSK cleavage site, 181-185, ELM|BRCT phosphopeptide ligands, 179-183, ELM",,,,,,,,,,,
196,184,L,,,,,,,,,,,C,"PCSK cleavage site, 181-185, ELM",,,,,,,,,,,
197,185,D,,,,,,,,,,,C,"PCSK cleavage site, 181-185, ELM",,,,,,,,,,,
198,186,A,,,,,,,,,,,C,,,,,,,,,,,,
199,187,L,,,,,,,,,,,C,,,,,,,,,,,,
200,188,Q,E,,,,,,,,,,C,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,16:3727641-3727641, hg38,16:3677640-3677640","hg19,16:g.3727641G>C, hg38,16:g.3677640G>C",0.194,lung,"carcinoma, adenocarcinoma",,
201,189,N,,,,,,,,,,,C,,,,,,,,,,,,
202,190,Q,,,,,,,,,,,C,,,,,,,,,,,,
203,191,A,,,,,,,,,,,C,"USP7 binding motif, 191-195, ELM",,,,,,,,,,,
204,192,E,D,,,,,,,,,,C,"USP7 binding motif, 191-195, ELM",,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018",Head and Neck Squamous Cell Carcinoma,"hg19,16:3727627-3727627, hg38,16:3677626-3677626","hg19,16:g.3727627C>A, hg38,16:g.3677626C>A",0.196,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",0.0000039789592634,0.0000318613394507
205,192,E,K,,,,,,,,,,C,"USP7 binding motif, 191-195, ELM",,"cBioPortal,Manual annotations from clinvar.csv","mel_ucla_2016, nhl_bcgsc_2013","Melanoma, Non-Hodgkin Lymphoma","hg19,16:3727629-3727629","hg19,16:g.3727629C>T",0.267,,,0.0015478028361796,0.0007327174259318
206,193,A,T,,,,,,,,,,C,"USP7 binding motif, 191-195, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,16:3727626-3727626, hg38,16:3677625-3677625","hg19,16:g.3727626C>T, hg38,16:g.3677625C>T",0.235,large_intestine,"carcinoma, adenocarcinoma",,
207,194,S,,P,,,,,,,,,C,"USP7 binding motif, 191-195, ELM",,,,,,,,,,,
208,195,S,,,,,,,,,,,C,"USP7 binding motif, 191-195, ELM",,,,,,,,,,,
209,196,K,,,,,,,,,,,C,,,,,,,,,,,,
210,197,I,,,,,,,,,,,C,,,,,,,,,,,,
211,198,I,,,,,,,,,,,C,,,,,,,,,,,,
212,199,G,S,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3727608-3727608","hg19,16:g.3727608C>T",0.968,,,0.0000079553229066,0.0000318796225453
213,200,Q,L,,,,,,,,,,C,,,COSMIC,,,"hg38,16:3677603-3677603","hg38,16:g.3677603T>A",0.973,"skin, mucosal, anorectal",malignant_melanoma,,
214,201,F,,,,,,,,,,,C,"Pex14 ligand motif, 201-205, ELM",,,,,,,,,,,
215,202,G,A,,,,,,,,,,S,"Pex14 ligand motif, 201-205, ELM",,cBioPortal,nsclc_mskcc_2018,Non-Small Cell Lung Cancer,"hg19,16:3727598-3727598","hg19,16:g.3727598C>G",0.946,,,,
216,203,V,,,,,,,,,,,S,"Pex14 ligand motif, 201-205, ELM",,,,,,,,,,,
217,204,G,,,,,,,,,,,S,"Pex14 ligand motif, 201-205, ELM",,,,,,,,,,,
218,205,F,,,,,,,,,,,S,"Pex14 ligand motif, 201-205, ELM|Pex14 ligand motif, 205-209, ELM",,,,,,,,,,,
219,206,Y,,,,,,,,,,,S,"Pex14 ligand motif, 205-209, ELM|Phosphotyrosine ligands bound by SH2 domains, 206-210, ELM|Y-based sorting signal, 206-209, ELM",,,,,,,,,,,
220,207,S,,,,,,,,,,,S,"Pex14 ligand motif, 205-209, ELM|Phosphotyrosine ligands bound by SH2 domains, 206-210, ELM|Y-based sorting signal, 206-209, ELM",,,,,,,,,,,
221,208,A,V,,,,,,,,,,S,"Pex14 ligand motif, 205-209, ELM|Phosphotyrosine ligands bound by SH2 domains, 206-210, ELM|Y-based sorting signal, 206-209, ELM",,COSMIC,,,"hg38,16:3677579-3677579","hg38,16:g.3677579G>A",0.565,liver,"other, neoplasm",,
222,209,F,L,,,,,,,,,,S,"Pex14 ligand motif, 205-209, ELM|Phosphotyrosine ligands bound by SH2 domains, 206-210, ELM|Y-based sorting signal, 206-209, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,16:3727578-3727578, hg38,16:3677577-3677577","hg19,16:g.3727578A>G, hg38,16:g.3677577A>G",0.943,skin,"carcinoma, basal_cell_carcinoma",,
223,210,M,T,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 206-210, ELM",,COSMIC,,,"hg38,16:3677573-3677573","hg38,16:g.3677573A>G",0.927,"upper_aerodigestive_tract, mouth, tongue","carcinoma, squamous_cell_carcinoma",0.0008192679085602,
224,211,V,,,,,,,,,,,S,,,,,,,,,,,,
225,212,A,,,,,,,,,,,S,,,,,,,,,,,,
226,213,D,N,,,,,,,,,,S,,,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,16:3727566-3727566","hg19,16:g.3727566C>T",0.488,,,,
227,214,R,,,,,,,,,,,S,,,,,,,,,,,,
228,215,V,,,,,,,,,,,S,,,,,,,,,,,,
229,216,E,,,,,,,,,,,S,,,,,,,,,,,,
230,217,V,A,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3677552-3677552","hg38,16:g.3677552A>G",0.862,pleura,"mesothelioma, sarcomatous-fibrous",,
231,217,V,I,,,,,,,,,,S,,,"cBioPortal,COSMIC",ampca_bcm_2016,Ampullary Carcinoma,"hg19,16:3727554-3727554, hg38,16:3677553-3677553","hg19,16:g.3727554C>T, hg38,16:g.3677553C>T",0.555,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",,
232,218,Y,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 218-222, ELM",,,,,,,,,,,
233,219,S,F,,,,,,,,,,S,"Tankyrase-binding motif, 219-226, ELM|Phosphotyrosine ligands bound by SH2 domains, 218-222, ELM",,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:3727547-3727547","hg19,16:g.3727547G>A",0.756,,,0.0000039776298099,
234,220,R,,,,,,,,,,,S,"Tankyrase-binding motif, 219-226, ELM|Phosphotyrosine ligands bound by SH2 domains, 218-222, ELM",,,,,,,,,,,
235,221,S,L,,,,,,,,,,S,"Tankyrase-binding motif, 219-226, ELM|Phosphotyrosine ligands bound by SH2 domains, 218-222, ELM",,COSMIC,,,"hg38,16:3677540-3677540","hg38,16:g.3677540G>A",0.477,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000119341236375,
236,222,A,E,,,,,,,,,,S,"Tankyrase-binding motif, 219-226, ELM|Phosphotyrosine ligands bound by SH2 domains, 218-222, ELM",,COSMIC,,,"hg38,16:3677537-3677537","hg38,16:g.3677537G>T",0.541,liver,"other, neoplasm",,
237,223,A,,,,,,,,,,,S,"Tankyrase-binding motif, 219-226, ELM",,,,,,,,,,,
238,224,P,L,,,,,,,,,,S,"Tankyrase-binding motif, 219-226, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,16:3677531-3677531","hg38,16:g.3677531G>A",0.159,"large_intestine, meninges","carcinoma, adenocarcinoma, meningioma, atypical",0.0001273074474857,0.0000636983247341
239,225,G,,,,,,,,,,,S,"Tankyrase-binding motif, 219-226, ELM",,,,,,,,,,,
240,226,S,R,,,,,,,,,,S,"Tankyrase-binding motif, 219-226, ELM|Atg8 protein family ligands, 226-234, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3727525-3727525","hg19,16:g.3727525G>C",0.439,,,0.0000159228062354,
241,227,L,,,,,,,,,,,S,"Atg8 protein family ligands, 226-234, ELM|Immunoreceptor tyrosine-based motif, 227-232, ELM",,,,,,,,,,,
242,228,G,,,,,,,,,,,S,"Atg8 protein family ligands, 226-234, ELM|Immunoreceptor tyrosine-based motif, 227-232, ELM",,,,,,,,,,,
243,229,Y,,,,,,,,,,,S,"Atg8 protein family ligands, 226-234, ELM|Immunoreceptor tyrosine-based motif, 227-232, ELM|Y-based sorting signal, 229-232, ELM",,,,,,,,,,,
244,230,Q,K,,,,,,,,,,S,"Atg8 protein family ligands, 226-234, ELM|Immunoreceptor tyrosine-based motif, 227-232, ELM|Y-based sorting signal, 229-232, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:3727515-3727515, hg38,16:3677514-3677514","hg19,16:g.3727515G>T, hg38,16:g.3677514G>T",0.220,skin,malignant_melanoma,,
245,230,Q,R,,,,,,,,,,S,"Atg8 protein family ligands, 226-234, ELM|Immunoreceptor tyrosine-based motif, 227-232, ELM|Y-based sorting signal, 229-232, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,16:3727514-3727514, hg38,16:3677513-3677513","hg19,16:g.3727514T>C, hg38,16:g.3677513T>C",0.223,lung,"carcinoma, adenocarcinoma",0.0000039787692871,
246,231,W,R,,,,,,,,,,S,"Atg8 protein family ligands, 226-234, ELM|Immunoreceptor tyrosine-based motif, 227-232, ELM|Y-based sorting signal, 229-232, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
247,232,L,,,,,,,,,,,S,"Atg8 protein family ligands, 226-234, ELM|Immunoreceptor tyrosine-based motif, 227-232, ELM|Y-based sorting signal, 229-232, ELM",,,,,,,,,,,
248,233,S,L,,,,,,,,,,S,"Atg8 protein family ligands, 226-234, ELM",,COSMIC,,,"hg38,16:3677504-3677504","hg38,16:g.3677504G>A",0.841,"skin, lower_leg",malignant_melanoma,,
249,234,D,H,,,,,,,,,,S,"Atg8 protein family ligands, 226-234, ELM",,COSMIC,,,"hg38,16:3677502-3677502","hg38,16:g.3677502C>G",0.599,"upper_aerodigestive_tract, mouth",carcinoma,0.0000039805431053,
250,235,G,,,,,,,,,,,S,"BRCT phosphopeptide ligands, 235-239, ELM",,,,,,,,,,,
251,236,S,,P,,,,,,,,,S,"BRCT phosphopeptide ligands, 235-239, ELM",,,,,,,,,,,
252,237,G,,,,,,,,,,,S,"BRCT phosphopeptide ligands, 235-239, ELM",,,,,,,,,,,
253,238,V,,,,,,,,,,,S,"BRCT phosphopeptide ligands, 235-239, ELM",,,,,,,,,,,
254,239,F,L,,,,,,,,,,S,"BRCT phosphopeptide ligands, 235-239, ELM",,COSMIC,,,"hg38,16:3676135-3676135","hg38,16:g.3676135A>G",0.828,lung,"carcinoma, adenocarcinoma",,
255,240,E,,,,,,,,,,,S,,,,,,,,,,,,
256,241,I,,,,,,,,,,,S,,,,,,,,,,,,
257,242,A,T,,,,,,,,,,S,"USP7 binding motif, 242-246, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,16:3726127-3726127","hg19,16:g.3726127C>T",0.266,,,0.0000398320680013,0.0001275103602168
258,242,A,V,,,,,,,,,,S,"USP7 binding motif, 242-246, ELM",,cBioPortal,skcm_broad,Cutaneous Melanoma,"hg19,16:3726126-3726126","hg19,16:g.3726126G>A",0.266,,,,
259,243,E,K,,,,,,,,,,S,"USP7 binding motif, 242-246, ELM",,cBioPortal,"prad_broad_2013, stad_oncosg_2018","Prostate Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:3726124-3726124","hg19,16:g.3726124C>T",0.557,,,0.0000995650996448,
260,244,A,G,,,,,,,,,,S,"USP7 binding motif, 242-246, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3726120-3726120","hg19,16:g.3726120G>C",0.636,,,,
261,245,S,L,,,,,,,,,,S,"USP7 binding motif, 242-246, ELM",,"cBioPortal,COSMIC",mel_dfci_2019,Melanoma,"hg19,16:3726117-3726117, hg38,16:3676116-3676116","hg19,16:g.3726117G>A, hg38,16:g.3676116G>A",0.493,oesophagus,"carcinoma, squamous_cell_carcinoma",0.0000437943417710,0.0000318694626809
262,246,G,,,,,,,,,,,S,"USP7 binding motif, 242-246, ELM",,,,,,,,,,,
263,247,V,I,,,,,,,,,,S,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,16:3726112-3726112, hg38,16:3676111-3676111","hg19,16:g.3726112C>T, hg38,16:g.3676111C>T",0.350,"skin, neck","carcinoma, basal_cell_carcinoma",,
264,248,R,,,,,,,,,,,S,"MAPK docking motifs, 248-257, ELM",,,,,,,,,,,
265,249,T,,,,,,,,,,,S,"MAPK docking motifs, 248-257, ELM|FHA phosphopeptide ligands, 249-255, ELM",,,,,,,,,,,
266,250,G,R,,,,,,,,,,S,"MAPK docking motifs, 248-257, ELM|FHA phosphopeptide ligands, 249-255, ELM",,COSMIC,,,"hg38,16:3676102-3676102","hg38,16:g.3676102C>T",0.885,"skin, trunk","malignant_melanoma, superficial_spreading",0.0000199130199290,0.0000319060685342
267,251,T,,,,,,,,,,,S,"MAPK docking motifs, 248-257, ELM|FHA phosphopeptide ligands, 249-255, ELM",,,,,,,,,,,
268,252,K,,,,,,,,,,,S,"MAPK docking motifs, 248-257, ELM|FHA phosphopeptide ligands, 249-255, ELM",,,,,,,,,,,
269,253,I,V,,,,,,,,,,S,"MAPK docking motifs, 248-257, ELM|FHA phosphopeptide ligands, 249-255, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
270,254,I,V,,,,,,,,,,S,"MAPK docking motifs, 248-257, ELM|FHA phosphopeptide ligands, 249-255, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,16:3726091-3726091, hg38,16:3676090-3676090","hg19,16:g.3726091T>C, hg38,16:g.3676090T>C",0.257,ovary,carcinoma,0.0000637140513376,0.0000637795777792
271,255,I,,,,,,,,,,,S,"MAPK docking motifs, 248-257, ELM|FHA phosphopeptide ligands, 249-255, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,,,,,,,,,,
272,256,H,,,,,,,,,,,S,"MAPK docking motifs, 248-257, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,,,,,,,,,,
273,257,L,,,,,,,,,,,S,"MAPK docking motifs, 248-257, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,,,,,,,,,,
274,258,K,,,,,,,,,,,S,"USP7 binding motif, 258-262, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,,,,,,,,,,
275,259,S,F,,,,,,,,,,S,"USP7 binding motif, 258-262, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,"cBioPortal,COSMIC",skcm_mskcc_2014,Cutaneous Melanoma,"hg19,16:3726075-3726075, hg38,16:3676074-3676074","hg19,16:g.3726075G>A, hg38,16:g.3676074G>A",0.348,lung,carcinoma,0.0577148320784032,0.0514424304314526
276,259,S,L,,,,,,,,,,S,"USP7 binding motif, 258-262, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
277,259,S,P,,,,,,,,,,S,"USP7 binding motif, 258-262, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,"cBioPortal,COSMIC","kirc_tcga, kirc_tcga_pan_can_atlas_2018, kirc_tcga_pub",Renal Clear Cell Carcinoma,"hg19,16:3726076-3726076, hg38,16:3676075-3676075","hg19,16:g.3726076A>G, hg38,16:g.3676075A>G",0.294,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
278,260,D,N,,,,,,,,,,S,"USP7 binding motif, 258-262, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,"cBioPortal,COSMIC","es_dfarber_broad_2014, pptc_2019","Ewing Sarcoma, Mixed Cancer Types","hg19,16:3726073-3726073, hg38,16:3676072-3676072","hg19,16:g.3726073C>T, hg38,16:g.3676072C>T",0.561,"bone, lung, prostate","Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour, carcinoma, adenocarcinoma",0.0001751996878260,0.0000318674314850
279,260,D,Y,,,,,,,,,,S,"USP7 binding motif, 258-262, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018",Bladder Urothelial Carcinoma,"hg19,16:3726073-3726073, hg38,16:3676072-3676072","hg19,16:g.3726073C>A, hg38,16:g.3676072C>A",0.903,"urinary_tract, bladder",carcinoma,,
280,261,C,R,,,,,,,,,,S,"USP7 binding motif, 258-262, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,COSMIC,,,"hg38,16:3676069-3676069","hg38,16:g.3676069A>G",0.438,lung,"carcinoma, adenocarcinoma",,
281,262,K,N,,,,,,,,,,S,"USP7 binding motif, 258-262, ELM|Binding motif for UBA3 adenylation domain, 253-262, ELM|Binding motif for UBA3 adenylation domain, 254-262, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:3726065-3726065, hg38,16:3676064-3676064","hg19,16:g.3726065C>A, hg38,16:g.3676064C>A",0.267,stomach,"carcinoma, adenocarcinoma",,
282,263,E,K,,,,,,,,,,S,,,"cBioPortal,COSMIC",skcm_yale,Cutaneous Melanoma,"hg19,16:3726064-3726064, hg38,16:3676063-3676063","hg19,16:g.3726064C>T, hg38,16:g.3676063C>T",0.587,skin,malignant_melanoma,,
283,264,F,,,,,,,,,,,S,,,,,,,,,,,,
284,265,S,,,,,,,,,,,S,,,,,,,,,,,,
285,266,S,,,,,,,,,,,S,,,,,,,,,,,,
286,267,E,K,,,,,,,,,,S,,,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:3726052-3726052, hg38,16:3676051-3676051","hg19,16:g.3726052C>T, hg38,16:g.3676051C>T",0.604,endometrium,"carcinoma, endometrioid_carcinoma",0.0000797314644278,0.0001593777891113
287,268,A,,,,,,,,,,,S,,,,,,,,,,,,
288,269,R,W,,,,,,,,,,S,,,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma","hg19,16:3726046-3726046, hg38,16:3676045-3676045","hg19,16:g.3726046G>A, hg38,16:g.3676045G>A",0.789,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",0.0000558931323310,0.0000318938572431
289,270,V,A,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3726042-3726042","hg19,16:g.3726042A>G",0.841,,,,
290,271,R,Q,,,,,,,,,,S,,,cBioPortal,gbm_mayo_pdx_sarkaria_2019,Glioblastoma Multiforme,"hg19,16:3726039-3726039","hg19,16:g.3726039C>T",0.135,,,0.0000760450186510,0.0000956327701626
291,272,D,,,,,,,,,,,S,,,,,,,,,,,,
292,273,V,M,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3725396-3725396","hg19,16:g.3725396C>T",0.661,,,,
293,274,V,L,,,,,,,,,,S,,,cBioPortal,utuc_cornell_baylor_mdacc_2019,Upper Tract Urothelial Carcinoma,"hg19,16:3725393-3725393","hg19,16:g.3725393C>A",0.409,,,,
294,275,T,M,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM",,"cBioPortal,Manual annotations from clinvar.csv",mpcproject_broad_2021,Prostate,"hg19,16:3725389-3725389","hg19,16:g.3725389G>A",0.371,,,0.0001034274257709,
295,276,K,,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM",,,,,,,,,,,
296,277,Y,,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM|Phosphotyrosine ligands bound by SH2 domains, 277-280, ELM|Phosphotyrosine ligands bound by SH2 domains, 277-281, ELM|Y-based sorting signal, 277-280, ELM",,,,,,,,,,,
297,278,S,,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM|Atg8 protein family ligands, 278-287, ELM|Phosphotyrosine ligands bound by SH2 domains, 277-280, ELM|Phosphotyrosine ligands bound by SH2 domains, 277-281, ELM|SH3 ligand, 278-284, ELM|Y-based sorting signal, 277-280, ELM",,,,,,,,,,,
298,279,N,,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM|Atg8 protein family ligands, 278-287, ELM|Phosphotyrosine ligands bound by SH2 domains, 277-280, ELM|Phosphotyrosine ligands bound by SH2 domains, 277-281, ELM|SH3 ligand, 278-284, ELM|Y-based sorting signal, 277-280, ELM",,,,,,,,,,,
299,280,F,L,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM|Atg8 protein family ligands, 278-287, ELM|Phosphotyrosine ligands bound by SH2 domains, 277-280, ELM|Phosphotyrosine ligands bound by SH2 domains, 277-281, ELM|SH3 ligand, 278-284, ELM|Y-based sorting signal, 277-280, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:3725375-3725375, hg38,16:3675374-3675374","hg19,16:g.3725375A>G, hg38,16:g.3675374A>G",0.907,stomach,"carcinoma, adenocarcinoma",,
300,281,V,I,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM|Atg8 protein family ligands, 278-287, ELM|Phosphotyrosine ligands bound by SH2 domains, 277-281, ELM|SH3 ligand, 278-284, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,16:3725372-3725372, hg38,16:3675371-3675371","hg19,16:g.3725372C>T, hg38,16:g.3675371C>T",0.179,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",0.0000278423012060,0.0000637592450905
301,282,S,,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM|Atg8 protein family ligands, 278-287, ELM|SH3 ligand, 278-284, ELM",,,,,,,,,,,
302,283,F,L,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM|Atg8 protein family ligands, 278-287, ELM|SH3 ligand, 278-284, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
303,284,P,H,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM|Atg8 protein family ligands, 278-287, ELM|SH3 ligand, 278-284, ELM",,COSMIC,,,"hg38,16:3675361-3675361","hg38,16:g.3675361G>T",0.823,placenta,choriocarcinoma,0.0000039774083207,
304,285,L,,,,,,,,,,,S,"Atg8 protein family ligands, 275-285, ELM|Atg8 protein family ligands, 278-287, ELM",,,,,,,,,,,
305,286,Y,,,,,,,,,,,S,"Atg8 protein family ligands, 278-287, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM",,,,,,,,,,,
306,287,L,,,,,,,,,,,S,"Atg8 protein family ligands, 278-287, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM",,,,,,,,,,,
307,288,N,,,,,,,,,,,S,"Integrin RGD-type binding sites, 288-290, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM",,,,,,,,,,,
308,289,G,E,,,,,,,,,,S,"Integrin RGD-type binding sites, 288-290, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM|Phosphotyrosine ligands bound by SH2 domains, 286-289, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,16:3725347-3725347","hg19,16:g.3725347C>T",0.536,,,,
309,290,R,,,,,,,,,,,S,"NRD cleavage site, 290-292, ELM|14-3-3 binding phosphopeptide motif, 290-296, ELM|Integrin RGD-type binding sites, 288-290, ELM|di Arginine retention/retrieving signal, 290-292, ELM",,,,,,,,,,,
310,291,R,,,,,,,,,,,S,"NRD cleavage site, 290-292, ELM|14-3-3 binding phosphopeptide motif, 290-296, ELM|14-3-3 binding phosphopeptide motif, 291-296, ELM|di Arginine retention/retrieving signal, 290-292, ELM",,,,,,,,,,,
311,292,M,I,,,,,,,,,,S,"NRD cleavage site, 290-292, ELM|14-3-3 binding phosphopeptide motif, 290-296, ELM|14-3-3 binding phosphopeptide motif, 291-296, ELM|di Arginine retention/retrieving signal, 290-292, ELM",,cBioPortal,"coadread_tcga_pan_can_atlas_2018, pancan_pcawg_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:3725337-3725337","hg19,16:g.3725337C>A",0.147,,,,
312,293,N,,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 290-296, ELM|14-3-3 binding phosphopeptide motif, 291-296, ELM",,,,,,,,,,,
313,294,T,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 290-296, ELM|14-3-3 binding phosphopeptide motif, 291-296, ELM",,,,,,,,,,,
314,295,L,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 290-296, ELM|14-3-3 binding phosphopeptide motif, 291-296, ELM",,,,,,,,,,,
315,296,Q,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 290-296, ELM|14-3-3 binding phosphopeptide motif, 291-296, ELM",,,,,,,,,,,
316,297,A,,,,,,,,,,,S,,,,,,,,,,,,
317,298,I,M,,,,,,,,,,S,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3724490-3724490, hg38,16:3674489-3674489","hg19,16:g.3724490G>C, hg38,16:g.3674489G>C",0.169,endometrium,"carcinoma, endometrioid_carcinoma",,
318,299,W,C,,,,,,,,,,S,,,"cBioPortal,COSMIC",ov_tcga_pan_can_atlas_2018,High-Grade Serous Ovarian Cancer,"hg19,16:3724487-3724487, hg38,16:3674486-3674486","hg19,16:g.3724487C>A, hg38,16:g.3674486C>A",0.738,ovary,"carcinoma, serous_carcinoma",0.0000039885130823,
319,300,M,T,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3674484-3674484","hg38,16:g.3674484A>G",0.226,large_intestine,"carcinoma, adenocarcinoma",,
320,301,M,I,,,,,,,,,,S,,,"cBioPortal,COSMIC",kirp_tcga_pan_can_atlas_2018,Papillary Renal Cell Carcinoma,"hg19,16:3724481-3724481, hg38,16:3674480-3674480","hg19,16:g.3724481C>A, hg38,16:g.3674480C>A, hg38,16:g.3674480C>T",0.222,"kidney, skin, extremity","carcinoma, papillary_renal_cell_carcinoma, malignant_melanoma, nodular",,
321,302,D,N,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3674479-3674479","hg38,16:g.3674479C>T",0.135,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
322,302,D,Y,,,,,,,,,,S,,,cBioPortal,stad_tcga,Stomach Adenocarcinoma,"hg19,16:3724480-3724480","hg19,16:g.3724480C>A",0.332,,,,
323,303,P,,,,,,,,,,,S,,,,,,,,,,,,
324,304,K,,,,,,,,,,,S,,,,,,,,,,,,
325,305,D,,,,,,,,,,,S,,,,,,,,,,,,
326,306,V,,,,,,,,,,,S,,,,,,,,,,,,
327,307,R,G,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","mds_mskcc_2020, sclc_cancercell_gardner_2017, skcm_mskcc_2014","Cutaneous Melanoma, Myelodysplastic Syndromes, Small Cell Lung Cancer","hg19,16:3724465-3724465, hg38,16:3674464-3674464","hg19,16:g.3724465G>C, hg38,16:g.3674464G>C",0.022,"haematopoietic_and_lymphoid_tissue, lung","carcinoma, sarcomatoid_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",0.4444466620894474,0.3618257261410788
328,308,E,,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 308-314, ELM",,,,,,,,,,,
329,309,W,,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 308-314, ELM",,,,,,,,,,,
330,310,Q,,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 308-314, ELM",,,,,,,,,,,
331,311,H,,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 308-314, ELM",,,,,,,,,,,
332,312,E,,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 308-314, ELM",,,,,,,,,,,
333,313,E,Q,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 308-314, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3724447-3724447","hg19,16:g.3724447C>G",0.239,,,0.0000199068360075,0.0001273804216292
334,314,F,,,,,,,,,,,S,"Di-Tryptophan targeting motif to the Delta-COP MHD domain, 308-314, ELM",,,,,,,,,,,
335,315,Y,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 315-319, ELM|Y-based sorting signal, 315-318, ELM",,,,,,,,,,,
336,316,R,H,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 315-319, ELM|Y-based sorting signal, 315-318, ELM",,cBioPortal,"paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,16:3724437-3724437","hg19,16:g.3724437C>T",0.352,,,0.0000159230597752,0.0000318491623670
337,317,Y,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 315-319, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM|Y-based sorting signal, 315-318, ELM",,,,,,,,,,,
338,318,V,I,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 315-319, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM|Y-based sorting signal, 315-318, ELM",,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,16:3724432-3724432","hg19,16:g.3724432C>T",0.065,,,0.0000159209049442,
339,319,A,E,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 315-319, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM",,"cBioPortal,COSMIC",brca_tcga_pan_can_atlas_2018,Invasive Breast Carcinoma,"hg19,16:3724428-3724428, hg38,16:3674427-3674427","hg19,16:g.3724428G>T, hg38,16:g.3674427G>T",0.363,breast,carcinoma,,
340,319,A,T,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 315-319, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,16:3724429-3724429, hg38,16:3674428-3674428","hg19,16:g.3724429C>T, hg38,16:g.3674428C>T",0.203,large_intestine,"carcinoma, adenocarcinoma",0.0000039803846644,
341,319,A,V,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 315-319, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","stad_tcga, stad_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:3724428-3724428, hg38,16:3674427-3674427","hg19,16:g.3724428G>A, hg38,16:g.3674427G>A",0.321,stomach,"carcinoma, adenocarcinoma",0.0000875621890547,0.0000318552497452
342,320,Q,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM|Phosphotyrosine ligands bound by SH2 domains, 317-320, ELM",,,,,,,,,,,
343,321,A,,,,,,,,,,,S,,,,,,,,,,,,
344,322,H,,,,,,,,,,,S,,,,,,,,,,,,
345,323,D,,,,,,,,,,,S,,,,,,,,,,,,
346,324,K,N,,,Ubq,,,Ac,,,,S,,,"cBioPortal,COSMIC",luad_tcga_pan_can_atlas_2018,Lung Adenocarcinoma,"hg19,16:3724412-3724412, hg38,16:3674411-3674411","hg19,16:g.3724412C>A, hg38,16:g.3674411C>A",0.043,"lung, right_upper_lobe","carcinoma, adenocarcinoma",0.0000039795609748,
347,325,P,,,,,,,,,,,S,,,,,,,,,,,,
348,326,R,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 326-330, ELM",,,,,,,,,,,
349,327,Y,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 326-330, ELM|Phosphotyrosine ligands bound by SH2 domains, 327-331, ELM|Phosphotyrosine ligands bound by SH2 domains, 327-330, ELM",,,,,,,,,,,
350,328,T,S,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 326-330, ELM|Phosphotyrosine ligands bound by SH2 domains, 327-331, ELM|Phosphotyrosine ligands bound by SH2 domains, 327-330, ELM",,"cBioPortal,COSMIC","blca_dfarber_mskcc_2014, blca_msk_tcga_2020",Bladder Urothelial Carcinoma,"hg19,16:3724401-3724401, hg38,16:3674400-3674400","hg19,16:g.3724401G>C, hg38,16:g.3674400G>C",0.164,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",0.0000079587418821,
351,329,L,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 326-330, ELM|Phosphotyrosine ligands bound by SH2 domains, 327-331, ELM|Phosphotyrosine ligands bound by SH2 domains, 327-330, ELM",,,,,,,,,,,
352,330,H,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 326-330, ELM|Phosphotyrosine ligands bound by SH2 domains, 327-331, ELM|Phosphotyrosine ligands bound by SH2 domains, 327-330, ELM",,,,,,,,,,,
353,331,Y,,P,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 327-331, ELM",,,,,,,,,,,
354,332,K,R,,,Ubq,,,Ac,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3724389-3724389","hg19,16:g.3724389T>C",0.081,,,0.0000039811452959,
355,333,T,M,P,,,,,,,,,S,,,"cBioPortal,COSMIC","mixed_allen_2018, ucec_tcga, ucec_tcga_pub","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:3724386-3724386, hg38,16:3674385-3674385","hg19,16:g.3724386G>A, hg38,16:g.3674385G>A",0.274,endometrium,"carcinoma, endometrioid_carcinoma",0.0000238878227842,0.0000318511912346
356,333,T,S,P,,,,,,,,,S,,,"cBioPortal,COSMIC","ccle_broad_2019, lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:3724387-3724387, hg38,16:3674386-3674386","hg19,16:g.3724387T>A, hg38,16:g.3674386T>A",0.092,lung,"carcinoma, squamous_cell_carcinoma",,
357,334,D,N,,,,,,,,,,C,,,"cBioPortal,COSMIC","cscc_ucsf_2021, skcm_broad","Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma","hg19,16:3724384-3724384, hg19,16:3724384-3724385, hg38,16:3674383-3674383","hg19,16:g.3724384C>T, hg19,16:g.3724384_3724385delinsTT, hg38,16:g.3674383C>T",0.467,"upper_aerodigestive_tract, mouth, lip","carcinoma, squamous_cell_carcinoma",,
358,335,A,T,,,,,,,,,,C,,,COSMIC,,,"hg38,16:3674380-3674380","hg38,16:g.3674380C>T",0.367,"large_intestine, colon, descending","carcinoma, adenocarcinoma",0.0000039836510959,
359,335,A,V,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3724380-3724380","hg19,16:g.3724380G>A",0.368,,,,
360,336,P,L,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3724377-3724377","hg19,16:g.3724377G>A",0.439,,,0.0000199206361854,
361,337,L,,,,,,,,,,,C,,,,,,,,,,,,
362,338,N,,,,,,,,,,,S,,,,,,,,,,,,
363,339,I,N,,,,,,,,,,S,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:3724368-3724368, hg38,16:3674367-3674367","hg19,16:g.3724368A>T, hg38,16:g.3674367A>T",0.606,stomach,"carcinoma, adenocarcinoma",,
364,340,R,C,,,,,,,,,,S,"PCSK cleavage site, 340-344, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, coadread_tcga_pan_can_atlas_2018, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, ucec_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Endometrial Carcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,16:3724366-3724366, hg38,16:3674365-3674365","hg19,16:g.3724366G>A, hg38,16:g.3674365G>A",0.465,"large_intestine, colon, ascending, stomach","carcinoma, adenocarcinoma",0.0000159409547038,
365,340,R,H,,,,,,,,,,S,"PCSK cleavage site, 340-344, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","dlbc_tcga, ucec_tcga_pan_can_atlas_2018","Diffuse Large B-Cell Lymphoma, NOS, Endometrial Carcinoma","hg19,16:3724365-3724365, hg38,16:3674364-3674364","hg19,16:g.3724365C>T, hg38,16:g.3674364C>T",0.430,endometrium,"carcinoma, endometrioid_carcinoma",0.0003986255391410,0.0003186133945071
366,341,S,C,P,,,,,,,,,S,"PCSK cleavage site, 340-344, ELM",,"cBioPortal,COSMIC",sclc_jhu,Small Cell Lung Cancer,"hg19,16:3724363-3724363, hg38,16:3674362-3674362","hg19,16:g.3724363T>A, hg38,16:g.3674362T>A",0.335,lung,"carcinoma, small_cell_carcinoma",,
367,342,I,M,,,,,,,,,,S,"PCSK cleavage site, 340-344, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,16:3724358-3724358, hg38,16:3674357-3674357","hg19,16:g.3724358G>C, hg38,16:g.3674357G>C",0.273,lung,"carcinoma, adenocarcinoma",0.0000079728286001,0.0000318511912346
368,343,F,,,,,,,,,,,S,"PCSK cleavage site, 340-344, ELM|PP4 EVH1-binding docking motifs, 343-346, ELM",,,,,,,,,,,
369,344,Y,,P,,,,,,,,,S,"PCSK cleavage site, 340-344, ELM|PP4 EVH1-binding docking motifs, 343-346, ELM|Phosphotyrosine ligands bound by SH2 domains, 344-347, ELM",,,,,,,,,,,
370,345,V,,,,,,,,,,,S,"PP4 EVH1-binding docking motifs, 343-346, ELM|Phosphotyrosine ligands bound by SH2 domains, 344-347, ELM",,,,,,,,,,,
371,346,P,H,,,,,,,,,,S,"PP4 EVH1-binding docking motifs, 343-346, ELM|Phosphotyrosine ligands bound by SH2 domains, 344-347, ELM",,"cBioPortal,COSMIC",stad_tcga_pan_can_atlas_2018,Stomach Adenocarcinoma,"hg19,16:3724347-3724347, hg38,16:3674346-3674346","hg19,16:g.3724347G>T, hg38,16:g.3674346G>T",0.519,stomach,"carcinoma, adenocarcinoma",,
372,347,D,N,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 344-347, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, coadread_dfci_2016, gbm_cptac_2021, gbm_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Glioblastoma Multiforme, Mixed Cancer Types","hg19,16:3724345-3724345, hg38,16:3674344-3674344","hg19,16:g.3724345C>T, hg38,16:g.3674344C>T",0.099,large_intestine,"carcinoma, adenocarcinoma",0.0000119770041520,
373,348,M,,,,,,,,,,,S,,,,,,,,,,,,
374,349,K,,,,,,,,,,,S,,,,,,,,,,,,
375,350,P,L,,,,,,,,,,S,,,"cBioPortal,COSMIC","pancan_pcawg_2020, skcm_tcga, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:3722817-3722817, hg38,16:3672816-3672816","hg19,16:g.3722817G>A, hg38,16:g.3672816G>A",0.524,skin,malignant_melanoma,0.0000081255230805,0.0000318796225453
376,351,S,,,,,,,,,,,C,,,,,,,,,,,,
377,352,M,,,,,,,,,,,C,,,,,,,,,,,,
378,353,F,,,,,,,,,,,C,,,,,,,,,,,,
379,354,D,,,,,,,,,,,C,,,,,,,,,,,,
380,355,V,,,,,,,,,,,C,,,,,,,,,,,,
381,356,S,,,,,,,,,,,C,,,,,,,,,,,,
382,357,R,,,,,,,,,,,C,,,,,,,,,,,,
383,358,E,,,,,,,,,,,C,,,,,,,,,,,,
384,359,L,,,,,,,,,,,C,,,,,,,,,,,,
385,360,G,,,,,,,,,,,C,,,,,,,,,,,,
386,361,S,,,,,,,,,,,C,,,,,,,,,,,,
387,362,S,,,,,,,,,,,S,,,,,,,,,,,,
388,363,V,I,,,,,,,,,,S,,,cBioPortal,prad_su2c_2019,Prostate Adenocarcinoma,"hg19,16:3722779-3722779","hg19,16:g.3722779C>T",0.040,,,0.0000851906241633,
389,364,A,T,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
390,365,L,,,,,,,,,,,S,,,,,,,,,,,,
391,366,Y,H,P,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 366-370, ELM|eIF4E binding motif, 366-372, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3722770-3722770","hg19,16:g.3722770A>G",0.627,,,,
392,367,S,,,,,,,,,,,S,"NRD cleavage site, 367-369, ELM|Phosphotyrosine ligands bound by SH2 domains, 366-370, ELM|eIF4E binding motif, 366-372, ELM",,,,,,,,,,,
393,368,R,H,,,,,,,,,,S,"NRD cleavage site, 367-369, ELM|PCSK cleavage site, 368-372, ELM|Phosphotyrosine ligands bound by SH2 domains, 366-370, ELM|eIF4E binding motif, 366-372, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3722763-3722763, hg38,16:3672762-3672762","hg19,16:g.3722763C>T, hg38,16:g.3672762C>T",0.631,"endometrium, large_intestine","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",0.0002336755108065,0.0000318897888896
394,369,K,,,,,,,,,,,S,"NRD cleavage site, 367-369, ELM|PCSK cleavage site, 368-372, ELM|Phosphotyrosine ligands bound by SH2 domains, 366-370, ELM|eIF4E binding motif, 366-372, ELM",,,,,,,,,,,
395,370,V,F,,,,,,,,,,S,"PCSK cleavage site, 368-372, ELM|Phosphotyrosine ligands bound by SH2 domains, 366-370, ELM|eIF4E binding motif, 366-372, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3722758-3722758","hg19,16:g.3722758C>A",0.467,,,0.0000040825991459,
396,371,L,I,,,,,,,,,,S,"PCSK cleavage site, 368-372, ELM|eIF4E binding motif, 366-372, ELM",,cBioPortal,"esca_tcga, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,16:3722755-3722755","hg19,16:g.3722755G>T",0.423,,,,
397,372,I,,,,,,,,,,,S,"PCSK cleavage site, 368-372, ELM|eIF4E binding motif, 366-372, ELM",,,,,,,,,,,
398,373,Q,K,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3672748-3672748","hg38,16:g.3672748G>T",0.422,liver,"other, neoplasm",,
399,374,T,,,,,,,,,,,S,,,,,,,,,,,,
400,375,K,,,,,,,,,,,S,"FHA phosphopeptide ligands, 375-381, ELM",,,,,,,,,,,
401,376,A,,,,,,,,,,,S,"FHA phosphopeptide ligands, 375-381, ELM",,,,,,,,,,,
402,377,T,M,,,,,,,,,,S,"FHA phosphopeptide ligands, 375-381, ELM",,"cBioPortal,COSMIC",cesc_tcga,Cervical Squamous Cell Carcinoma,"hg19,16:3722736-3722736, hg38,16:3672735-3672735","hg19,16:g.3722736G>A, hg38,16:g.3672735G>A",0.160,cervix,"carcinoma, squamous_cell_carcinoma",0.0000372584411068,0.0000318654005481
403,378,D,,,,,,,,,,,S,"FHA phosphopeptide ligands, 375-381, ELM",,,,,,,,,,,
404,379,I,L,,,,,,,,,,S,"FHA phosphopeptide ligands, 375-381, ELM",,"cBioPortal,COSMIC",gbm_tcga_pan_can_atlas_2018,Glioblastoma Multiforme,"hg19,16:3722731-3722731, hg38,16:3672730-3672730","hg19,16:g.3722731T>G, hg38,16:g.3672730T>G",0.183,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
405,380,L,M,,,,,,,,,,S,"PP1-docking motif RVXF, 380-387, ELM|FHA phosphopeptide ligands, 375-381, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3722728-3722728","hg19,16:g.3722728G>T",0.280,,,,
406,381,P,H,,,,,,,,,,S,"PP1-docking motif RVXF, 380-387, ELM|FHA phosphopeptide ligands, 375-381, ELM",,COSMIC,,,"hg38,16:3672723-3672723","hg38,16:g.3672723G>T",0.782,liver,"other, neoplasm",,
407,381,P,S,,,,,,,,,,S,"PP1-docking motif RVXF, 380-387, ELM|FHA phosphopeptide ligands, 375-381, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, ucec_cptac_2020","Colorectal Adenocarcinoma, Endometrial Carcinoma","hg19,16:3722725-3722725, hg38,16:3672724-3672724","hg19,16:g.3722725G>A, hg38,16:g.3672724G>A",0.808,"large_intestine, large_intestine, colon, transverse","carcinoma, adenocarcinoma",,
408,382,K,,,,Ubq,,,Ac,,,,S,"PP1-docking motif RVXF, 380-387, ELM",,,,,,,,,,,
409,383,W,,,,,,,,,,,S,"PP1-docking motif RVXF, 380-387, ELM",,,,,,,,,,,
410,384,L,,,,,,,,,,,S,"PP1-docking motif RVXF, 380-387, ELM",,,,,,,,,,,
411,385,R,C,,,,,,,,,,S,"PP1-docking motif RVXF, 380-387, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,16:3722713-3722713","hg19,16:g.3722713G>A",0.631,,,0.0000335432582244,
412,385,R,H,,,,,,,,,,S,"PP1-docking motif RVXF, 380-387, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3722712-3722712","hg19,16:g.3722712C>T",0.522,,,0.0000544981973673,0.0000637186185803
413,386,F,,,,,,,,,,,S,"PP1-docking motif RVXF, 380-387, ELM",,,,,,,,,,,
414,387,I,,,,,,,,,,,S,"PP1-docking motif RVXF, 380-387, ELM",,,,,,,,,,,
415,388,R,Q,,Me,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","acc_tcga, paad_tcga, paad_tcga_pan_can_atlas_2018","Adrenocortical Carcinoma, Pancreatic Adenocarcinoma","hg19,16:3722703-3722703, hg38,16:3672702-3672702","hg19,16:g.3722703C>T, hg38,16:g.3672702C>T",0.266,breast,"carcinoma, ER-positive_carcinoma",0.0003043573832029,0.0002866972477064
416,389,G,,,,,,,,,,,S,,,,,,,,,,,,
417,390,V,,,,,,,,,,,S,,,,,,,,,,,,
418,391,V,A,,,,,,,,,,S,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,16:3721786-3721786, hg38,16:3671785-3671785","hg19,16:g.3721786A>G, hg38,16:g.3671785A>G",0.714,lung,"carcinoma, squamous_cell_carcinoma",0.0000199979202163,
419,392,D,,,,,,,,,,,S,,,,,,,,,,,,
420,393,S,,P,,,,,,,,,S,,,,,,,,,,,,
421,394,E,,,,,,,,,,,S,,,,,,,,,,,,
422,395,D,E,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","mds_mskcc_2020, mixed_pipseq_2017","Mixed Cancer Types, Myelodysplastic Syndromes","hg19,16:3721773-3721773, hg38,16:3671772-3671772","hg19,16:g.3721773G>C, hg38,16:g.3671772G>C",0.281,"breast, haematopoietic_and_lymphoid_tissue, large_intestine","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",0.1500520083213314,0.1328294425309351
423,395,D,G,,,,,,,,,,S,,,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:3721774-3721774, hg38,16:3671773-3671773","hg19,16:g.3721774T>C, hg38,16:g.3671773T>C",0.683,"large_intestine, colon","carcinoma, adenocarcinoma",,
424,396,I,V,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
425,397,P,L,,,,,,,,,,S,"CtBP ligand motif, 397-401, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,16:3721767-3721768, hg38,16:3671766-3671767","hg19,16:g.3721767_3721768delinsAA, hg38,16:g.3671766_3671767delinsAA",,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
426,398,L,,,,,,,,,,,C,"CtBP ligand motif, 397-401, ELM",,,,,,,,,,,
427,399,N,,,,,,,,,,,C,"Cyclin N-terminal Domain Docking Motifs, 399-408, ELM|CtBP ligand motif, 397-401, ELM",,,,,,,,,,,
428,400,L,F,,,,,,,,,,C,"Cyclin N-terminal Domain Docking Motifs, 399-408, ELM|CtBP ligand motif, 397-401, ELM",,"cBioPortal,COSMIC",metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,16:3721760-3721760, hg38,16:3671759-3671759","hg19,16:g.3721760G>A, hg38,16:g.3671759G>A",0.475,"skin, head_neck","carcinoma, Merkel_cell_carcinoma",0.0000039955250120,
429,400,L,I,,,,,,,,,,C,"Cyclin N-terminal Domain Docking Motifs, 399-408, ELM|CtBP ligand motif, 397-401, ELM",,cBioPortal,coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,16:3721760-3721760","hg19,16:g.3721760G>T",0.232,,,,
430,401,S,,P,,,,,,,,,C,"Cyclin N-terminal Domain Docking Motifs, 399-408, ELM|CtBP ligand motif, 397-401, ELM",,,,,,,,,,,
431,402,R,L,,,,,,,,,,C,"PCSK cleavage site, 402-406, ELM|Cyclin N-terminal Domain Docking Motifs, 399-408, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:3721753-3721753, hg38,16:3671752-3671752","hg19,16:g.3721753C>A, hg38,16:g.3671752C>A",0.810,"adrenal_gland, adrenal_gland, skin","adrenal_cortical_carcinoma, functioning, malignant_melanoma",,
432,402,R,Q,,,,,,,,,,C,"PCSK cleavage site, 402-406, ELM|Cyclin N-terminal Domain Docking Motifs, 399-408, ELM",,"cBioPortal,COSMIC",coadread_genentech,Colorectal Adenocarcinoma,"hg19,16:3721753-3721753, hg38,16:3671752-3671752","hg19,16:g.3721753C>T, hg38,16:g.3671752C>T",0.743,"large_intestine, colon, lung","carcinoma, adenocarcinoma",0.0000159898943867,
433,402,R,W,,,,,,,,,,C,"PCSK cleavage site, 402-406, ELM|Cyclin N-terminal Domain Docking Motifs, 399-408, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:3721754-3721754, hg38,16:3671753-3671753","hg19,16:g.3721754G>A, hg38,16:g.3671753G>A",0.832,endometrium,"carcinoma, endometrioid_carcinoma",0.0000359758242461,
434,403,E,,,,,,,,,,,C,"PCSK cleavage site, 402-406, ELM|Cyclin N-terminal Domain Docking Motifs, 399-408, ELM",,,,,,,,,,,
435,404,L,,,,,,,,,,,C,"PCSK cleavage site, 402-406, ELM|Cyclin N-terminal Domain Docking Motifs, 399-408, ELM",,,,,,,,,,,
436,405,L,,,,,,,,,,,C,"PCSK cleavage site, 402-406, ELM|Cyclin N-terminal Domain Docking Motifs, 399-408, ELM",,,,,,,,,,,
437,406,Q,K,,,,,,,,,,C,"PCSK cleavage site, 402-406, ELM|Cyclin N-terminal Domain Docking Motifs, 399-408, ELM",,COSMIC,,,"hg38,16:3671741-3671741","hg38,16:g.3671741G>T",0.593,liver,"other, neoplasm",,
438,407,E,D,,,,,,,,,,C,"Cyclin N-terminal Domain Docking Motifs, 399-408, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,16:3721737-3721737, hg38,16:3671736-3671736","hg19,16:g.3721737C>G, hg38,16:g.3671736C>G",0.198,breast,carcinoma,,
439,408,S,G,,,,,,,,,,C,"Cyclin N-terminal Domain Docking Motifs, 399-408, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3721736-3721736","hg19,16:g.3721736T>C",0.299,,,,
440,408,S,N,,,,,,,,,,C,"Cyclin N-terminal Domain Docking Motifs, 399-408, ELM",,"cBioPortal,COSMIC",cesc_tcga_pan_can_atlas_2018,Cervical Squamous Cell Carcinoma,"hg19,16:3721735-3721735, hg38,16:3671734-3671734","hg19,16:g.3721735C>T, hg38,16:g.3671734C>T",0.146,cervix,"carcinoma, squamous_cell_carcinoma",,
441,409,A,,,,,,,,,,,C,,,,,,,,,,,,
442,410,L,P,,,,,,,,,,C,"Cyclin D-specific Helical docking motif, 410-421, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3721729-3721729, hg38,16:3671728-3671728","hg19,16:g.3721729A>G, hg38,16:g.3671728A>G",0.667,endometrium,"carcinoma, endometrioid_carcinoma",,
443,411,I,N,,,,,,,,,,S,"NRD cleavage site, 411-413, ELM|Cyclin D-specific Helical docking motif, 410-421, ELM",,cBioPortal,"stad_tcga, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:3721726-3721726","hg19,16:g.3721726A>T",0.596,,,0.0000040078875226,
444,412,R,,,,,,,,,,,S,"NRD cleavage site, 411-413, ELM|Cyclin D-specific Helical docking motif, 410-421, ELM",,,,,,,,,,,
445,413,K,,,,,,,,,,,S,"NRD cleavage site, 411-413, ELM|Cyclin D-specific Helical docking motif, 410-421, ELM",,,,,,,,,,,
446,414,L,,,,,,,,,,,S,"Cyclin D-specific Helical docking motif, 410-421, ELM",,,,,,,,,,,
447,415,R,Q,,,,,,,,,,S,"PCSK cleavage site, 415-419, ELM|Cyclin D-specific Helical docking motif, 410-421, ELM",,"cBioPortal,COSMIC",stad_tcga_pan_can_atlas_2018,Stomach Adenocarcinoma,"hg19,16:3716111-3716111, hg38,16:3666110-3666110","hg19,16:g.3716111C>T, hg38,16:g.3666110C>T",0.164,stomach,"carcinoma, adenocarcinoma",0.0000161159055930,0.0000318410494810
448,416,D,,,,,,,,,,,S,"PCSK cleavage site, 415-419, ELM|Cyclin D-specific Helical docking motif, 410-421, ELM|NES Nuclear Export Signal, 416-428, ELM",,,,,,,,,,,
449,417,V,,,,,,,,,,,S,"PCSK cleavage site, 415-419, ELM|Cyclin D-specific Helical docking motif, 410-421, ELM|NES Nuclear Export Signal, 416-428, ELM",,,,,,,,,,,
450,418,L,,,,,,,,,,,S,"PCSK cleavage site, 415-419, ELM|Cyclin D-specific Helical docking motif, 410-421, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 418-423, ELM|NES Nuclear Export Signal, 416-428, ELM",,,,,,,,,,,
451,419,Q,,,,,,,,,,,S,"PCSK cleavage site, 415-419, ELM|Cyclin D-specific Helical docking motif, 410-421, ELM|PP1-docking motif RVXF, 419-426, ELM|PCNA binding PIP Box, 419-428, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 418-423, ELM|NES Nuclear Export Signal, 416-428, ELM",,,,,,,,,,,
452,420,Q,H,,,,,,,,,,S,"Cyclin D-specific Helical docking motif, 410-421, ELM|PP1-docking motif RVXF, 419-426, ELM|PCNA binding PIP Box, 419-428, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 418-423, ELM|NES Nuclear Export Signal, 416-428, ELM",,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,16:3716095-3716095, hg38,16:3666094-3666094","hg19,16:g.3716095C>G, hg38,16:g.3666094C>G",0.127,lung,"carcinoma, adenocarcinoma",,
453,421,R,,,,,,,,,,,S,"PCSK cleavage site, 421-425, ELM|Cyclin D-specific Helical docking motif, 410-421, ELM|PP1-docking motif RVXF, 419-426, ELM|PCNA binding PIP Box, 419-428, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 418-423, ELM|NES Nuclear Export Signal, 416-428, ELM",,,,,,,,,,,
454,422,L,,,,,,,,,,,S,"PCSK cleavage site, 421-425, ELM|PP1-docking motif RVXF, 419-426, ELM|PCNA binding PIP Box, 419-428, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 418-423, ELM|NES Nuclear Export Signal, 416-428, ELM",,,,,,,,,,,
455,423,I,M,,,,,,,,,,S,"PCSK cleavage site, 421-425, ELM|PP1-docking motif RVXF, 419-426, ELM|PCNA binding PIP Box, 419-428, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 418-423, ELM|NES Nuclear Export Signal, 416-428, ELM",,COSMIC,,,"hg38,16:3666085-3666085","hg38,16:g.3666085G>C",0.256,liver,"other, neoplasm",0.0000079615932740,
456,424,K,Q,,,,,,Ac,,,,S,"PCSK cleavage site, 421-425, ELM|PP1-docking motif RVXF, 419-426, ELM|PCNA binding PIP Box, 419-428, ELM|NES Nuclear Export Signal, 416-428, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3716085-3716085, hg38,16:3666084-3666084","hg19,16:g.3716085T>G, hg38,16:g.3666084T>G",0.208,endometrium,"carcinoma, endometrioid_carcinoma",,
457,425,F,,,,,,,,,,,S,"PCSK cleavage site, 421-425, ELM|PP1-docking motif RVXF, 419-426, ELM|PCNA binding PIP Box, 419-428, ELM|NES Nuclear Export Signal, 416-428, ELM",,,,,,,,,,,
458,426,F,,,,,,,,,,,S,"PP1-docking motif RVXF, 419-426, ELM|PCNA binding PIP Box, 419-428, ELM|NES Nuclear Export Signal, 416-428, ELM",,,,,,,,,,,
459,427,I,N,,,,,,,,,,S,"PCNA binding PIP Box, 419-428, ELM|NES Nuclear Export Signal, 416-428, ELM",,COSMIC,,,"hg38,16:3666074-3666074","hg38,16:g.3666074A>T",0.154,cervix,"carcinoma, squamous_cell_carcinoma",0.0000039796876741,0.0000318430773150
460,428,D,G,,,,,,,,,,S,"PCNA binding PIP Box, 419-428, ELM|NES Nuclear Export Signal, 416-428, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3716072-3716072, hg38,16:3666071-3666071","hg19,16:g.3716072T>C, hg38,16:g.3666071T>C",0.311,endometrium,"carcinoma, endometrioid_carcinoma",0.0000039786426463,
461,429,Q,H,,,,,,,,,,S,,,cBioPortal,"brca_mbcproject_2022, brca_mbcproject_wagle_2017",Invasive Breast Carcinoma,"hg19,16:3716068-3716068","hg19,16:g.3716068C>G",0.300,,,,
462,430,S,,,,,,,,,,,S,"Caspase cleavage motif, 430-434, ELM",,,,,,,,,,,
463,431,K,,,,,,,Ac,,,,S,"Caspase cleavage motif, 430-434, ELM",,,,,,,,,,,
464,432,K,,,,,,,Ac,,,,S,"Caspase cleavage motif, 430-434, ELM|USP7 binding motif, 432-436, ELM",,,,,,,,,,,
465,433,D,H,,,,,,,,,,S,"Caspase cleavage motif, 430-434, ELM|USP7 binding motif, 432-436, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,16:3716058-3716058","hg19,16:g.3716058C>G",0.316,,,0.0000039783260795,
466,434,A,V,,,,,,,,,,S,"Caspase cleavage motif, 430-434, ELM|USP7 binding motif, 432-436, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:3716054-3716054, hg38,16:3666053-3666053","hg19,16:g.3716054G>A, hg38,16:g.3666053G>A",0.108,stomach,"carcinoma, adenocarcinoma",,
467,435,E,,,,,,,,,,,S,"USP7 binding motif, 432-436, ELM|Atg8 protein family ligands, 435-444, ELM",,,,,,,,,,,
468,436,K,,,,,,,Ac,,,,S,"PCSK cleavage site, 436-440, ELM|USP7 binding motif, 432-436, ELM|Atg8 protein family ligands, 435-444, ELM",,,,,,,,,,,
469,437,Y,,,,,,,,,,,S,"PCSK cleavage site, 436-440, ELM|Atg8 protein family ligands, 435-444, ELM|Phosphotyrosine ligands bound by SH2 domains, 437-441, ELM|Y-based sorting signal, 437-440, ELM",,,,,,,,,,,
470,438,A,,,,,,,,,,,S,"PCSK cleavage site, 436-440, ELM|Atg8 protein family ligands, 435-444, ELM|Phosphotyrosine ligands bound by SH2 domains, 437-441, ELM|Y-based sorting signal, 437-440, ELM",,,,,,,,,,,
471,439,K,R,,,,,,,,,,S,"PCSK cleavage site, 436-440, ELM|Atg8 protein family ligands, 435-444, ELM|Phosphotyrosine ligands bound by SH2 domains, 437-441, ELM|Y-based sorting signal, 437-440, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3716039-3716039","hg19,16:g.3716039T>C",0.018,,,,
472,439,K,T,,,,,,,,,,S,"PCSK cleavage site, 436-440, ELM|Atg8 protein family ligands, 435-444, ELM|Phosphotyrosine ligands bound by SH2 domains, 437-441, ELM|Y-based sorting signal, 437-440, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3716039-3716039","hg19,16:g.3716039T>G",0.112,,,,
473,440,F,S,,,,,,,,,,S,"PCSK cleavage site, 436-440, ELM|Atg8 protein family ligands, 435-444, ELM|Phosphotyrosine ligands bound by SH2 domains, 437-441, ELM|Y-based sorting signal, 437-440, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3716036-3716036","hg19,16:g.3716036A>G",0.660,,,,
474,441,F,,,,,,,,,,,S,"Atg8 protein family ligands, 435-444, ELM|Phosphotyrosine ligands bound by SH2 domains, 437-441, ELM",,,,,,,,,,,
475,442,E,K,,,,,,,,,,S,"Atg8 protein family ligands, 435-444, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
476,443,D,H,,,,,,,,,,S,"Atg8 protein family ligands, 435-444, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3716028-3716028","hg19,16:g.3716028C>G",0.353,,,,
477,443,D,N,,,,,,,,,,S,"Atg8 protein family ligands, 435-444, ELM",,cBioPortal,cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,16:3716028-3716028","hg19,16:g.3716028C>T",0.164,,,,
478,444,Y,N,P,,,,,,,,,S,"Atg8 protein family ligands, 435-444, ELM|Y-based sorting signal, 444-447, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
479,445,G,,,,,,,,,,,S,"Y-based sorting signal, 444-447, ELM",,,,,,,,,,,
480,446,L,,,,,,,,,,,S,"Y-based sorting signal, 444-447, ELM",,,,,,,,,,,
481,447,F,,,,,,,,,,,S,"Y-based sorting signal, 444-447, ELM",,,,,,,,,,,
482,448,M,,,,,,,,,,,S,,,,,,,,,,,,
483,449,R,Q,,,,,,,,,,S,,,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,16:3716009-3716009, hg38,16:3666008-3666008","hg19,16:g.3716009C>T, hg38,16:g.3666008C>T",0.374,liver,"carcinoma, hepatocellular_carcinoma",0.0000119361178970,0.0002230151650312
484,449,R,W,,,,,,,,,,S,,,cBioPortal,"ccle_broad_2019, pptc_2019",Mixed Cancer Types,"hg19,16:3716010-3716010","hg19,16:g.3716010G>A",0.436,,,0.0000437852770016,
485,450,E,,,,,,,,,,,S,,,,,,,,,,,,
486,451,G,,,,,,,,,,,S,,,,,,,,,,,,
487,452,I,,,,,,,,,,,S,"FHA phosphopeptide ligands, 452-458, ELM",,,,,,,,,,,
488,453,V,,,,,,,,,,,S,"FHA phosphopeptide ligands, 452-458, ELM",,,,,,,,,,,
489,454,T,A,,,,,,,,,,S,"FHA phosphopeptide ligands, 452-458, ELM|FHA phosphopeptide ligands, 454-460, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,16:3715995-3715995","hg19,16:g.3715995T>C",0.265,,,,
490,455,A,,,,,,,,,,,S,"FHA phosphopeptide ligands, 452-458, ELM|FHA phosphopeptide ligands, 454-460, ELM",,,,,,,,,,,
491,456,T,,,,,,,,,,,C,"FHA phosphopeptide ligands, 452-458, ELM|FHA phosphopeptide ligands, 454-460, ELM|TRAF2 binding site, 456-459, ELM",,,,,,,,,,,
492,457,E,K,,,,,,,,,,S,"FHA phosphopeptide ligands, 452-458, ELM|FHA phosphopeptide ligands, 454-460, ELM|TRAF2 binding site, 456-459, ELM",,"cBioPortal,COSMIC","mel_ucla_2016, prad_su2c_2019, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Melanoma, Prostate Adenocarcinoma","hg19,16:3715986-3715986, hg38,16:3665985-3665985","hg19,16:g.3715986C>T, hg38,16:g.3665985C>T",0.281,endometrium,"carcinoma, endometrioid_carcinoma",0.0000518510836876,
493,458,Q,,,,,,,,,,,S,"FHA phosphopeptide ligands, 452-458, ELM|FHA phosphopeptide ligands, 454-460, ELM|TRAF2 binding site, 456-459, ELM",,,,,,,,,,,
494,459,E,D,,,,,,,,,,S,"FHA phosphopeptide ligands, 454-460, ELM|TRAF2 binding site, 456-459, ELM",,cBioPortal,"stad_tcga, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:3715978-3715978","hg19,16:g.3715978C>A",0.102,,,,
495,460,V,,,,,,,,,,,S,"FHA phosphopeptide ligands, 454-460, ELM",,,,,,,,,,,
496,461,K,,,,Ubq,,,,,,,S,,,,,,,,,,,,
497,462,E,,,,,,,,,,,S,,,,,,,,,,,,
498,463,D,N,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3714457-3714457","hg19,16:g.3714457C>T",0.143,,,0.0000000000000000,
499,464,I,,,,,,,,,,,S,,,,,,,,,,,,
500,465,A,S,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3664450-3664450","hg38,16:g.3664450C>A",0.366,thyroid,carcinoma,,
501,466,K,,,,,,,Ac,,,,S,,,,,,,,,,,,
502,467,L,,,,,,,,,,,S,,,,,,,,,,,,
503,468,L,,,,,,,,,,,S,,,,,,,,,,,,
504,469,R,H,,,,,,,,,,S,,,"cBioPortal,COSMIC",mbl_icgc,Medulloblastoma,"hg19,16:3714438-3714438, hg38,16:3664437-3664437","hg19,16:g.3714438C>T, hg38,16:g.3664437C>T",0.819,"central_nervous_system, brain, haematopoietic_and_lymphoid_tissue, large_intestine, colon","lymphoid_neoplasm, plasma_cell_myeloma, other, primitive_neuroectodermal_tumour-medulloblastoma",0.0054953172837783,0.0073998468997193
505,470,Y,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 470-474, ELM",,,,,,,,,,,
506,471,E,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 470-474, ELM",,,,,,,,,,,
507,472,S,F,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 470-474, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,16:3714429-3714429, hg38,16:3664428-3664428","hg19,16:g.3714429G>A, hg38,16:g.3664428G>A",0.694,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
508,473,S,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 470-474, ELM",,,,,,,,,,,
509,474,A,,,,,,,,,,,C,"USP7 binding motif, 474-478, ELM|Phosphotyrosine ligands bound by SH2 domains, 470-474, ELM",,,,,,,,,,,
510,475,L,,,,,,,,,,,S,"USP7 binding motif, 474-478, ELM",,,,,,,,,,,
511,476,P,,,,,,,,,,,C,"USP7 binding motif, 474-478, ELM",,,,,,,,,,,
512,477,S,C,,,,,,,,,,C,"USP7 binding motif, 474-478, ELM",,cBioPortal,utuc_cornell_baylor_mdacc_2019,Upper Tract Urothelial Carcinoma,"hg19,16:3714414-3714414","hg19,16:g.3714414G>C",0.191,,,0.0000041160393823,
513,477,S,F,,,,,,,,,,C,"USP7 binding motif, 474-478, ELM",,"cBioPortal,COSMIC","mixed_allen_2018, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,16:3714414-3714414, hg38,16:3664413-3664413","hg19,16:g.3714414G>A, hg38,16:g.3664413G>A",0.165,"skin, skin, upper_leg","malignant_melanoma, malignant_melanoma, superficial_spreading",,
514,478,G,,,,,,,,,,,C,"USP7 binding motif, 474-478, ELM",,,,,,,,,,,
515,479,Q,H,,,,,,,,,,S,,,COSMIC,,,"hg38,16:3664406-3664406","hg38,16:g.3664406C>G",0.205,"biliary_tract, bile_duct",carcinoma,,
516,480,L,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 480-486, ELM",,,,,,,,,,,
517,481,T,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 480-486, ELM",,,,,,,,,,,
518,482,S,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 480-486, ELM",,,,,,,,,,,
519,483,L,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 480-486, ELM",,,,,,,,,,,
520,484,S,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 480-486, ELM",,,,,,,,,,,
521,485,E,Q,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 480-486, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3714391-3714391","hg19,16:g.3714391C>G",0.216,,,0.0000040854012273,
522,486,Y,,P,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 480-486, ELM|Phosphotyrosine ligands bound by SH2 domains, 486-490, ELM",,,,,,,,,,,
523,487,A,T,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 486-490, ELM",,"cBioPortal,COSMIC","ampca_bcm_2016, utuc_igbmc_2021","Ampullary Carcinoma, Upper Tract Urothelial Carcinoma","hg19,16:3714385-3714385, hg38,16:3664384-3664384","hg19,16:g.3714385C>T, hg38,16:g.3664384C>T",0.033,"haematopoietic_and_lymphoid_tissue, small_intestine, duodenum","carcinoma, adenocarcinoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia",0.0000081990062804,0.0000637592450905
524,488,S,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 486-490, ELM",,,,,,,,,,,
525,489,R,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 486-490, ELM",,,,,,,,,,,
526,490,M,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 486-490, ELM",,,,,,,,,,,
527,491,R,L,,,,,,,,,,C,,,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,16:3714372-3714372, hg38,16:3664371-3664371","hg19,16:g.3714372C>A, hg38,16:g.3664371C>A",0.080,skin,malignant_melanoma,,
528,491,R,W,,,,,,,,,,C,,,"cBioPortal,COSMIC","ccle_broad_2019, coadread_dfci_2016","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:3714373-3714373, hg38,16:3664372-3664372","hg19,16:g.3714373G>A, hg38,16:g.3664372G>A",0.111,"large_intestine, large_intestine, colon, transverse","carcinoma, adenocarcinoma",0.0000122022647403,
529,492,A,,,,,,,,,,,C,"FHA phosphopeptide ligands, 492-498, ELM",,,,,,,,,,,
530,493,G,,,,,,,,,,,C,"FHA phosphopeptide ligands, 492-498, ELM",,,,,,,,,,,
531,494,T,,P,,,,,,,,,C,"FHA phosphopeptide ligands, 492-498, ELM",,,,,,,,,,,
532,495,R,C,,,,,,,,,,C,"FHA phosphopeptide ligands, 492-498, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,16:3714361-3714361, hg38,16:3664360-3664360","hg19,16:g.3714361G>A, hg38,16:g.3664360G>A",0.426,"large_intestine, colon, transverse","carcinoma, adenocarcinoma",0.0000202217926215,0.0000637511156445
533,496,N,,,,,,,,,,,S,"FHA phosphopeptide ligands, 492-498, ELM",,,,,,,,,,,
534,497,I,,,,,,,,,,,S,"FHA phosphopeptide ligands, 492-498, ELM",,,,,,,,,,,
535,498,Y,,P,,,,,,,,,C,"FHA phosphopeptide ligands, 492-498, ELM",,,,,,,,,,,
536,499,Y,,P,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 499-502, ELM",,,,,,,,,,,
537,500,L,,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 500-503, ELM|Phosphotyrosine ligands bound by SH2 domains, 499-502, ELM",,,,,,,,,,,
538,501,C,,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 500-503, ELM|Phosphotyrosine ligands bound by SH2 domains, 499-502, ELM",,,,,,,,,,,
539,502,A,T,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 500-503, ELM|Phosphotyrosine ligands bound by SH2 domains, 499-502, ELM",,COSMIC,,,"hg38,16:3664339-3664339","hg38,16:g.3664339C>T",0.225,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0000161626610205,
540,503,P,,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 500-503, ELM",,,,,,,,,,,
541,504,N,,,,,,,,,,,C,,,,,,,,,,,,
542,505,R,,,Me,,,,,,,,C,,,,,,,,,,,,
543,506,H,,,,,,,,,,,C,,,,,,,,,,,,
544,507,L,,,,,,,,,,,C,,,,,,,,,,,,
545,508,A,,,,,,,,,,,C,"WW domain ligands, 508-513, ELM",,,,,,,,,,,
546,509,E,,,,,,,,,,,C,"WW domain ligands, 508-513, ELM",,,,,,,,,,,
547,510,H,,,,,,,,,,,C,"WW domain ligands, 508-513, ELM",,,,,,,,,,,
548,511,S,,P,,,,,,,,,C,"WW domain ligands, 508-513, ELM|Atg8 protein family ligands, 511-521, ELM",,,,,,,,,,,
549,512,P,,,,,,,,,,,C,"WW domain ligands, 508-513, ELM|Atg8 protein family ligands, 511-521, ELM",,,,,,,,,,,
550,513,Y,C,P,,,,,,,,,C,"WW domain ligands, 508-513, ELM|Atg8 protein family ligands, 511-521, ELM",,COSMIC,,,"hg38,16:3664305-3664305","hg38,16:g.3664305T>C",0.610,endometrium,"hyperplasia, atypical",,
551,514,Y,,P,,,,,,,,,C,"Atg8 protein family ligands, 511-521, ELM|Y-based sorting signal, 514-517, ELM",,,,,,,,,,,
552,515,E,,,,,,,,,,,C,"Atg8 protein family ligands, 511-521, ELM|Y-based sorting signal, 514-517, ELM",,,,,,,,,,,
553,516,A,,,,,,,,,,,C,"Atg8 protein family ligands, 511-521, ELM|Y-based sorting signal, 514-517, ELM",,,,,,,,,,,
554,517,M,T,,,,,,,,,,C,"Atg8 protein family ligands, 511-521, ELM|Y-based sorting signal, 514-517, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3714294-3714294, hg38,16:3664293-3664293","hg19,16:g.3714294A>G, hg38,16:g.3664293A>G",0.569,endometrium,"carcinoma, endometrioid_carcinoma",,
555,518,K,T,,,,,,Ac,,,,C,"MAPK docking motifs, 518-526, ELM|Atg8 protein family ligands, 511-521, ELM",,COSMIC,,,"hg38,16:3664290-3664290","hg38,16:g.3664290T>G",0.343,stomach,carcinoma,,
556,519,K,,,,,,,,,,,C,"MAPK docking motifs, 518-526, ELM|MAPK docking motifs, 519-526, ELM|Atg8 protein family ligands, 511-521, ELM",,,,,,,,,,,
557,520,K,,,,,,,,,,,C,"MAPK docking motifs, 518-526, ELM|MAPK docking motifs, 519-526, ELM|FHA phosphopeptide ligands, 520-526, ELM|Atg8 protein family ligands, 511-521, ELM",,,,,,,,,,,
558,521,D,,,,,,,,,,,C,"MAPK docking motifs, 518-526, ELM|MAPK docking motifs, 519-526, ELM|FHA phosphopeptide ligands, 520-526, ELM|Atg8 protein family ligands, 511-521, ELM|Rb pocket B binding ligand, 521-543, ELM",,,,,,,,,,,
559,522,T,R,,,,,,,,,,C,"MAPK docking motifs, 518-526, ELM|MAPK docking motifs, 519-526, ELM|FHA phosphopeptide ligands, 520-526, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM",,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,16:3714279-3714279, hg38,16:3664278-3664278","hg19,16:g.3714279G>C, hg38,16:g.3664278G>C",0.274,large_intestine,"carcinoma, adenocarcinoma",,
560,523,E,K,,,,,,,,,,C,"MAPK docking motifs, 518-526, ELM|MAPK docking motifs, 519-526, ELM|FHA phosphopeptide ligands, 520-526, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM",,COSMIC,,,"hg38,16:3664276-3664276","hg38,16:g.3664276C>T",0.658,lung,"carcinoma, mixed_adenosquamous_carcinoma",,
561,524,V,,,,,,,,,,,S,"MAPK docking motifs, 518-526, ELM|MAPK docking motifs, 519-526, ELM|FHA phosphopeptide ligands, 520-526, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM",,,,,,,,,,,
562,525,L,F,,,,,,,,,,S,"MAPK docking motifs, 518-526, ELM|MAPK docking motifs, 519-526, ELM|Clathrin box, 525-529, ELM|FHA phosphopeptide ligands, 520-526, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3713560-3713560","hg19,16:g.3713560G>A",0.765,,,,
563,525,L,V,,,,,,,,,,S,"MAPK docking motifs, 518-526, ELM|MAPK docking motifs, 519-526, ELM|Clathrin box, 525-529, ELM|FHA phosphopeptide ligands, 520-526, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM",,cBioPortal,"luad_mskcc_2015, mixed_allen_2018","Lung Adenocarcinoma, Mixed Cancer Types","hg19,16:3713560-3713560","hg19,16:g.3713560G>C",0.472,,,,
564,526,F,L,,,,,,,,,,S,"MAPK docking motifs, 518-526, ELM|MAPK docking motifs, 519-526, ELM|Clathrin box, 525-529, ELM|FHA phosphopeptide ligands, 520-526, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3713557-3713557","hg19,16:g.3713557A>G",0.321,,,,
565,527,C,,,,,,,,,,,S,"Clathrin box, 525-529, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM",,,,,,,,,,,
566,528,F,,,,,,,,,,,S,"Clathrin box, 525-529, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM",,,,,,,,,,,
567,529,E,,,,,,,,,,,S,"Clathrin box, 525-529, ELM|Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM",,,,,,,,,,,
568,530,Q,,,,,,,,,,,S,"Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM",,,,,,,,,,,
569,531,F,,,,,,,,,,,S,"Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM",,,,,,,,,,,
570,532,D,,,,,,,,,,,S,"Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|SUMO interaction site, 532-538, ELM",,,,,,,,,,,
571,533,E,,,,,,,,,,,S,"Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|SUMO interaction site, 532-538, ELM|SUMO interaction site, 533-538, ELM",,,,,,,,,,,
572,534,L,,,,,,,,,,,S,"Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|SUMO interaction site, 532-538, ELM|SUMO interaction site, 533-538, ELM",,,,,,,,,,,
573,535,T,,,,,,,,,,,S,"Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|SUMO interaction site, 532-538, ELM|SUMO interaction site, 533-538, ELM",,,,,,,,,,,
574,536,L,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 536-542, ELM|Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|SUMO interaction site, 532-538, ELM|SUMO interaction site, 533-538, ELM|Binding motif for UBA3 adenylation domain, 536-544, ELM",,,,,,,,,,,
575,537,L,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 536-542, ELM|Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|SUMO interaction site, 532-538, ELM|SUMO interaction site, 533-538, ELM|Binding motif for UBA3 adenylation domain, 536-544, ELM",,,,,,,,,,,
576,538,H,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 536-542, ELM|Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|SUMO interaction site, 532-538, ELM|SUMO interaction site, 533-538, ELM|Binding motif for UBA3 adenylation domain, 536-544, ELM",,,,,,,,,,,
577,539,L,F,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 536-542, ELM|Atg8 protein family ligands, 529-539, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|Binding motif for UBA3 adenylation domain, 536-544, ELM",,"cBioPortal,COSMIC",skcm_broad_brafresist_2012,Cutaneous Melanoma,"hg19,16:3713518-3713518, hg38,16:3663517-3663517","hg19,16:g.3713518G>A, hg38,16:g.3663517G>A",0.396,,malignant_melanoma,,
578,540,R,G,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 536-542, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|Binding motif for UBA3 adenylation domain, 536-544, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3713515-3713515","hg19,16:g.3713515G>C",0.255,,,0.0000039772501293,
579,540,R,H,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 536-542, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|Binding motif for UBA3 adenylation domain, 536-544, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, paad_tcga, paad_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma","hg19,16:3713514-3713514, hg38,16:3663513-3663513","hg19,16:g.3713514C>T, hg38,16:g.3663513C>T",0.133,"large_intestine, large_intestine, colon","carcinoma, adenocarcinoma",0.0000159088739699,
580,541,E,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 536-542, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|Binding motif for UBA3 adenylation domain, 536-544, ELM",,,,,,,,,,,
581,542,F,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 536-542, ELM|Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|Binding motif for UBA3 adenylation domain, 536-544, ELM",,,,,,,,,,,
582,543,D,N,,,,,,,,,,S,"Rb pocket B binding ligand, 521-543, ELM|Rb pocket B binding ligand, 522-543, ELM|Rb pocket B binding ligand, 523-543, ELM|Binding motif for UBA3 adenylation domain, 536-544, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3713506-3713506","hg19,16:g.3713506C>T",0.119,,,0.0000039769337841,
583,544,K,T,,,,,,,,,,C,"MAPK docking motifs, 544-550, ELM|Binding motif for UBA3 adenylation domain, 536-544, ELM",,"cBioPortal,COSMIC",skcm_yale,Cutaneous Melanoma,"hg19,16:3713502-3713502, hg38,16:3663501-3663501","hg19,16:g.3713502T>G, hg38,16:g.3663501T>G",0.135,skin,malignant_melanoma,,
584,545,K,N,,,,,,,,,,S,"MAPK docking motifs, 544-550, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3713498-3713498","hg19,16:g.3713498C>A",0.228,,,,
585,546,K,Q,,,,,,,,,,S,"MAPK docking motifs, 544-550, ELM|SUMO interaction site, 546-553, ELM",,"cBioPortal,COSMIC","paad_qcmg_uq_2016, prad_tcga, prad_tcga_pan_can_atlas_2018, prad_tcga_pub","Pancreatic Adenocarcinoma, Prostate Adenocarcinoma","hg19,16:3713497-3713497, hg38,16:3663496-3663496","hg19,16:g.3713497T>G, hg38,16:g.3663496T>G",0.119,"pancreas, prostate","carcinoma, adenocarcinoma, carcinoma, ductal_carcinoma",0.0003579183468945,0.0004140918646875
586,546,K,R,,,,,,,,,,S,"MAPK docking motifs, 544-550, ELM|SUMO interaction site, 546-553, ELM",,cBioPortal,blca_cornell_2016,Bladder Urothelial Carcinoma,"hg19,16:3713496-3713496","hg19,16:g.3713496T>C",0.170,,,0.0000159071025213,0.0000318532203606
587,547,L,,,,,,,,,,,S,"MAPK docking motifs, 544-550, ELM|Clathrin box, 547-551, ELM|SUMO interaction site, 546-553, ELM",,,,,,,,,,,
588,548,I,,,,,,,,,,,S,"MAPK docking motifs, 544-550, ELM|Clathrin box, 547-551, ELM|SUMO interaction site, 546-553, ELM",,,,,,,,,,,
589,549,S,Y,,,,,,,,,,S,"MAPK docking motifs, 544-550, ELM|Clathrin box, 547-551, ELM|SUMO interaction site, 546-553, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3713487-3713487","hg19,16:g.3713487G>T",0.532,,,0.0000039768072601,
590,550,V,,,,,,,,,,,S,"MAPK docking motifs, 544-550, ELM|Clathrin box, 547-551, ELM|FHA phosphopeptide ligands, 550-556, ELM|SUMO interaction site, 546-553, ELM",,,,,,,,,,,
591,551,E,,,,,,,,,,,C,"Clathrin box, 547-551, ELM|FHA phosphopeptide ligands, 550-556, ELM|SUMO interaction site, 546-553, ELM",,,,,,,,,,,
592,552,T,M,,,,,,,,,,C,"FHA phosphopeptide ligands, 550-556, ELM|SUMO interaction site, 546-553, ELM",,cBioPortal,"coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,16:3713478-3713478","hg19,16:g.3713478G>A",0.377,,,0.0000715853774936,
593,553,D,Y,,,,,,,,,,C,"FHA phosphopeptide ligands, 550-556, ELM|SUMO interaction site, 546-553, ELM",,COSMIC,,,"hg38,16:3663475-3663475","hg38,16:g.3663475C>A",0.438,thyroid,"other, neoplasm",,
594,554,I,,,,,,,,,,,D,"FHA phosphopeptide ligands, 550-556, ELM",,,,,,,,,,,
595,555,V,,,,,,,,,,,D,"FHA phosphopeptide ligands, 550-556, ELM",,,,,,,,,,,
596,556,V,M,,,,,,,,,,D,"FHA phosphopeptide ligands, 550-556, ELM",,COSMIC,,,"hg38,16:3663466-3663466","hg38,16:g.3663466C>T",0.124,"lung, stomach","carcinoma, carcinoma, intestinal_adenocarcinoma, carcinoma, squamous_cell_carcinoma",0.0000198851434117,0.0000318471337580
597,557,D,N,,,,,,,,,,D,,,"cBioPortal,COSMIC",ov_tcga_pan_can_atlas_2018,High-Grade Serous Ovarian Cancer,"hg19,16:3713464-3713464, hg38,16:3663463-3663463","hg19,16:g.3713464C>T, hg38,16:g.3663463C>T",0.115,ovary,"carcinoma, serous_carcinoma",,
598,558,H,,,,,,,,,,,D,,,,,,,,,,,,
599,559,Y,H,,,,,,,,,,D,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3713458-3713458","hg19,16:g.3713458A>G",0.193,,,,
600,560,K,,,,,,,,,,,D,,,,,,,,,,,,
601,561,E,,,,,,,,,,,D,,,,,,,,,,,,
602,562,E,,,,,,,,,,,s,,,,,,,,,,,,
603,563,K,,,,,,,,,,,s,,,,,,,,,,,,
604,564,F,,,,,,,,,,,s,,,,,,,,,,,,
605,565,E,,,,,,,,,,,s,"WW domain ligands, 565-570, ELM",,,,,,,,,,,
606,566,D,,,,,,,,,,,s,"WW domain ligands, 565-570, ELM",,,,,,,,,,,
607,567,R,,,Me,,,,,,,,s,"WW domain ligands, 565-570, ELM",,,,,,,,,,,
608,568,S,,P,,,,,,,,,s,"WW domain ligands, 565-570, ELM",,,,,,,,,,,
609,569,P,Q,,,,,,,,,,s,"WW domain ligands, 565-570, ELM",,cBioPortal,lusc_tcga_pub,Lung Squamous Cell Carcinoma,"hg19,16:3713427-3713427","hg19,16:g.3713427G>T",0.077,,,,
610,570,A,,,,,,,,,,,s,"WW domain ligands, 565-570, ELM",,,,,,,,,,,
611,571,A,T,,,,,,,,,,s,,,"cBioPortal,COSMIC","coadread_genentech, lihc_tcga, lihc_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Hepatocellular Carcinoma","hg19,16:3712966-3712966, hg38,16:3662965-3662965","hg19,16:g.3712966C>T, hg38,16:g.3662965C>T",0.037,"central_nervous_system, brain, large_intestine, colon, liver, oesophagus, upper_aerodigestive_tract, mouth, gingiva","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, squamous_cell_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000204966754392,
612,572,E,K,,,,,,,,,,s,,,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,16:3712963-3712963","hg19,16:g.3712963C>T",0.127,,,0.0000817487696810,
613,573,C,,,,,,,,,,,s,,,,,,,,,,,,
614,574,L,,,,,,,,,,,s,,,,,,,,,,,,
615,575,S,,,,,,,,,,,s,,,,,,,,,,,,
616,576,E,D,,,,,,,,,,s,,,cBioPortal,"pancan_pcawg_2020, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:3712949-3712949","hg19,16:g.3712949C>A",0.018,,,,
617,577,K,,,,,,,,,,,s,"FHA phosphopeptide ligands, 577-583, ELM",,,,,,,,,,,
618,578,E,,,,,,,,,,,s,"FHA phosphopeptide ligands, 577-583, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 578-583, ELM",,,,,,,,,,,
619,579,T,M,,,,,,,,,,s,"FHA phosphopeptide ligands, 577-583, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 578-583, ELM",,"cBioPortal,COSMIC","prad_p1000, prad_tcga, prad_tcga_pan_can_atlas_2018",Prostate Adenocarcinoma,"hg19,16:3712941-3712941, hg38,16:3662940-3662940","hg19,16:g.3712941G>A, hg38,16:g.3662940G>A",0.041,"prostate, stomach","carcinoma, carcinoma, adenocarcinoma",0.0001644948003595,0.0002550044625781
620,580,E,,,,,,,,,,,s,"FHA phosphopeptide ligands, 577-583, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 578-583, ELM",,,,,,,,,,,
621,581,E,,,,,,,,,,,s,"FHA phosphopeptide ligands, 577-583, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 578-583, ELM",,,,,,,,,,,
622,582,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 577-583, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 578-583, ELM",,,,,,,,,,,
623,583,M,V,,,,,,,,,,s,"FHA phosphopeptide ligands, 577-583, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 578-583, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,16:3712930-3712930, hg38,16:3662929-3662929","hg19,16:g.3712930T>C, hg38,16:g.3662929T>C",0.041,stomach,"carcinoma, adenocarcinoma",0.0000079991041003,0.0000637348629700
624,584,A,,,,,,,,,,,s,,,,,,,,,,,,
625,585,W,,,,,,,,,,,s,,,,,,,,,,,,
626,586,M,I,,,,,,,,,,s,,,"cBioPortal,COSMIC","blca_dfarber_mskcc_2014, blca_msk_tcga_2020, utuc_igbmc_2021","Bladder Urothelial Carcinoma, Upper Tract Urothelial Carcinoma","hg19,16:3712919-3712919, hg38,16:3662918-3662918","hg19,16:g.3712919C>T, hg38,16:g.3662918C>T",0.073,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
627,587,R,G,,,,,,,,,,s,"PCSK cleavage site, 587-591, ELM",,COSMIC,,,"hg38,16:3662917-3662917","hg38,16:g.3662917T>C",0.239,stomach,carcinoma,,
628,588,N,,,,,,,,,,,s,"PCSK cleavage site, 587-591, ELM",,,,,,,,,,,
629,589,V,L,,,,,,,,,,s,"PCSK cleavage site, 587-591, ELM",,cBioPortal,mel_ucla_2016,Melanoma,"hg19,16:3712912-3712912","hg19,16:g.3712912C>A",0.083,,,,
630,590,L,,,,,,,,,,,s,"PCSK cleavage site, 587-591, ELM",,,,,,,,,,,
631,591,G,,,,,,,,,,,s,"PCSK cleavage site, 587-591, ELM",,,,,,,,,,,
632,592,S,L,,,,,,,,,,s,,,cBioPortal,prad_p1000,Prostate Adenocarcinoma,"hg19,16:3712902-3712902","hg19,16:g.3712902G>A",0.048,,,0.0000598898027629,0.0000955962016443
633,593,R,C,,,,,,,,,,s,"MAPK docking motifs, 593-601, ELM",,COSMIC,,,"hg38,16:3662899-3662899","hg38,16:g.3662899G>A",0.298,"large_intestine, colon, right","carcinoma, adenocarcinoma",0.0000039923665951,
634,593,R,H,,,,,,,,,,s,"MAPK docking motifs, 593-601, ELM",,cBioPortal,"ccle_broad_2019, mm_broad","Mixed Cancer Types, Plasma Cell Myeloma","hg19,16:3712899-3712899","hg19,16:g.3712899C>T",0.175,,,0.0000997908384027,
635,594,V,,,,,,,,,,,s,"MAPK docking motifs, 593-601, ELM",,,,,,,,,,,
636,595,T,,,,,,,,,,,s,"MAPK docking motifs, 593-601, ELM",,,,,,,,,,,
637,596,N,,,,,,,,,,,s,"MAPK docking motifs, 593-601, ELM",,,,,,,,,,,
638,597,V,,,,,,,,,,,s,"MAPK docking motifs, 593-601, ELM",,,,,,,,,,,
639,598,K,,,,,,,,,,,s,"MAPK docking motifs, 593-601, ELM|FHA phosphopeptide ligands, 598-604, ELM",,,,,,,,,,,
640,599,V,,,,,,,,,,,s,"MAPK docking motifs, 593-601, ELM|FHA phosphopeptide ligands, 598-604, ELM",,,,,,,,,,,
641,600,T,P,,,,,,,,,,s,"MAPK docking motifs, 593-601, ELM|FHA phosphopeptide ligands, 598-604, ELM",,COSMIC,,,"hg38,16:3662129-3662129","hg38,16:g.3662129T>G",0.692,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
642,601,L,I,,,,,,,,,,s,"MAPK docking motifs, 593-601, ELM|FHA phosphopeptide ligands, 598-604, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3712127-3712127, hg38,16:3662126-3662126","hg19,16:g.3712127G>T, hg38,16:g.3662126G>T",0.018,endometrium,"carcinoma, endometrioid_carcinoma",,
643,602,R,Q,,,,,,,,,,s,"FHA phosphopeptide ligands, 598-604, ELM",,"cBioPortal,COSMIC",es_dfarber_broad_2014,Ewing Sarcoma,"hg19,16:3712123-3712123, hg38,16:3662122-3662122","hg19,16:g.3712123C>T, hg38,16:g.3662122C>T",0.542,bone,Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour,0.0004239257151708,0.0011476664116297
644,603,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 598-604, ELM",,,,,,,,,,,
645,604,D,N,,,,,,,,,,s,"FHA phosphopeptide ligands, 598-604, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3712118-3712118","hg19,16:g.3712118C>T",0.201,,,0.0000162663782096,
646,605,T,P,,,,,,,,,,s,,,COSMIC,,,"hg38,16:3662114-3662114","hg38,16:g.3662114T>G",0.514,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",0.0000326658609088,
647,606,H,P,,,,,,,,,,s,,,COSMIC,,,"hg38,16:3662110-3662110","hg38,16:g.3662110T>G",0.582,"upper_aerodigestive_tract, mouth, tongue","carcinoma, squamous_cell_carcinoma",0.0000946572174071,
648,607,P,H,,,,,,,,,,s,,,COSMIC,,,"hg38,16:3662107-3662107","hg38,16:g.3662107G>T",0.877,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
649,608,A,S,,,,,,,,,,s,"SUMO interaction site, 608-614, ELM",,COSMIC,,,"hg38,16:3662105-3662105","hg38,16:g.3662105C>A",0.228,lung,"carcinoma, mixed_adenosquamous_carcinoma",0.0001216258949639,
650,609,M,,,,,,,,,,,s,"FHA phosphopeptide ligands, 609-615, ELM|SUMO interaction site, 608-614, ELM",,,,,,,,,,,
651,610,V,,,,,,,,,,,s,"FHA phosphopeptide ligands, 609-615, ELM|SUMO interaction site, 608-614, ELM",,,,,,,,,,,
652,611,T,,,,,,,,,,,s,"FHA phosphopeptide ligands, 609-615, ELM|SUMO interaction site, 608-614, ELM",,,,,,,,,,,
653,612,V,M,,,,,,,,,,s,"FHA phosphopeptide ligands, 609-615, ELM|SUMO interaction site, 608-614, ELM",,COSMIC,,,"hg38,16:3662093-3662093","hg38,16:g.3662093C>T",0.347,"large_intestine, colon, transverse","carcinoma, adenocarcinoma",0.0000486133054617,
654,613,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 609-615, ELM|SUMO interaction site, 608-614, ELM",,,,,,,,,,,
655,614,E,Q,,,,,,,,,,s,"FHA phosphopeptide ligands, 609-615, ELM|SUMO interaction site, 608-614, ELM",,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,16:3712088-3712089",,,,,,
656,615,M,R,,,,,,,,,,s,"FHA phosphopeptide ligands, 609-615, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3712084-3712084","hg19,16:g.3712084A>C",0.570,,,,
657,616,G,,,,,,,,,,,s,,,,,,,,,,,,
658,617,A,,,,,,,,,,,s,,,,,,,,,,,,
659,618,A,,,,,,,,,,,s,,,,,,,,,,,,
660,619,R,H,,,,,,,,,,s,"PCSK cleavage site, 619-623, ELM",,"cBioPortal,COSMIC","coad_cptac_2019, prad_fhcrc","Colon Adenocarcinoma, Prostate Adenocarcinoma","hg19,16:3712072-3712072, hg38,16:3662071-3662071","hg19,16:g.3712072C>T, hg38,16:g.3662071C>T",0.510,prostate,"carcinoma, adenocarcinoma",0.0000121628853608,0.0000318816552955
661,620,H,,,,,,,,,,,s,"PCSK cleavage site, 619-623, ELM",,,,,,,,,,,
662,621,F,,,,,,,,,,,s,"PCSK cleavage site, 619-623, ELM",,,,,,,,,,,
663,622,L,Q,,,,,,,,,,s,"PCSK cleavage site, 619-623, ELM",,"cBioPortal,COSMIC",es_dfarber_broad_2014,Ewing Sarcoma,"hg19,16:3712063-3712063, hg38,16:3662062-3662062","hg19,16:g.3712063A>T, hg38,16:g.3662062A>T",0.630,"bone, pelvis",Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour,0.0000687029687765,0.0000318633698700
664,623,R,C,,,,,,,,,,s,"PCSK cleavage site, 619-623, ELM",,cBioPortal,"ccle_broad_2019, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,16:3712061-3712061","hg19,16:g.3712061G>A",0.698,,,0.0000525894222445,
665,624,M,,,,,,,,,,,s,,,,,,,,,,,,
666,625,Q,,,,,,,,,,,s,,,,,,,,,,,,
667,626,Q,H,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3712050-3712050","hg19,16:g.3712050C>A",0.215,,,0.0000040424620211,
668,627,L,,,,,,,,,,,s,,,,,,,,,,,,
669,628,A,,,,,,,,,,,s,"FHA phosphopeptide ligands, 628-634, ELM",,,,,,,,,,,
670,629,K,,,,,,,,,,,s,"FHA phosphopeptide ligands, 628-634, ELM",,,,,,,,,,,
671,630,T,,,,,,,,,,,s,"FHA phosphopeptide ligands, 628-634, ELM|TRAF2 binding site, 630-633, ELM",,,,,,,,,,,
672,631,Q,,,,,,,,,,,s,"FHA phosphopeptide ligands, 628-634, ELM|TRAF2 binding site, 630-633, ELM",,,,,,,,,,,
673,632,E,K,,,,,,,,,,s,"FHA phosphopeptide ligands, 628-634, ELM|TRAF2 binding site, 630-633, ELM",,cBioPortal,bcc_unige_2016,Basal Cell Carcinoma,"hg19,16:3712034-3712034","hg19,16:g.3712034C>T",0.257,,,,
674,632,E,Q,,,,,,,,,,s,"FHA phosphopeptide ligands, 628-634, ELM|TRAF2 binding site, 630-633, ELM",,COSMIC,,,"hg38,16:3662033-3662033","hg38,16:g.3662033C>G",0.160,oesophagus,"carcinoma, squamous_cell_carcinoma",,
675,633,E,K,,,,,,,,,,s,"FHA phosphopeptide ligands, 628-634, ELM|TRAF2 binding site, 630-633, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 633-638, ELM",,cBioPortal,mel_dfci_2019,Melanoma,"hg19,16:3712031-3712031","hg19,16:g.3712031C>T",0.281,,,0.0000081024145195,
676,634,R,,,,,,,,,,,s,"FHA phosphopeptide ligands, 628-634, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 633-638, ELM",,,,,,,,,,,
677,635,A,T,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 633-638, ELM",,"cBioPortal,COSMIC","esca_broad, gbm_tcga_pan_can_atlas_2018","Esophageal Adenocarcinoma, Glioblastoma Multiforme","hg19,16:3712025-3712025, hg38,16:3662024-3662024","hg19,16:g.3712025C>T, hg38,16:g.3662024C>T",0.258,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",0.0000324849351113,0.0000318735258494
678,636,Q,R,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 633-638, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,16:3712021-3712021, hg38,16:3662020-3662020","hg19,16:g.3712021T>C, hg38,16:g.3662020T>C",0.326,endometrium,"carcinoma, endometrioid_carcinoma",,
679,637,L,F,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 633-638, ELM",,"cBioPortal,COSMIC",ampca_bcm_2016,Ampullary Carcinoma,"hg19,16:3712019-3712019, hg38,16:3662018-3662018","hg19,16:g.3712019G>A, hg38,16:g.3662018G>A",0.044,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",,
680,638,L,,,,,,,,,,,s,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 633-638, ELM",,,,,,,,,,,
681,639,Q,R,,,,,,,,,,s,"FHA phosphopeptide ligands, 639-645, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,16:3712012-3712012","hg19,16:g.3712012T>C",0.354,,,0.0000040826991541,
682,640,P,,,,,,,,,,,s,"FHA phosphopeptide ligands, 639-645, ELM",,,,,,,,,,,
683,641,T,M,,,,,,,,,,s,"FHA phosphopeptide ligands, 639-645, ELM",,COSMIC,,,"hg38,16:3662005-3662005","hg38,16:g.3662005G>A",0.462,"large_intestine, rectum","carcinoma, adenocarcinoma",0.0014685733507265,
684,642,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 639-645, ELM",,,,,,,,,,,
685,643,E,K,,,,,,,,,,s,"FHA phosphopeptide ligands, 639-645, ELM",,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,16:3712001-3712001, hg38,16:3662000-3662000","hg19,16:g.3712001C>T, hg38,16:g.3662000C>T",0.621,skin,malignant_melanoma,0.0001069228428316,0.0001274453578028
686,644,I,,,,,,,,,,,s,"FHA phosphopeptide ligands, 639-645, ELM",,,,,,,,,,,
687,645,N,,,,,,,,,,,s,"FHA phosphopeptide ligands, 639-645, ELM",,,,,,,,,,,
688,646,P,,,,,,,,,,,s,,,,,,,,,,,,
689,647,R,T,,,,,,,,,,s,"PCSK cleavage site, 647-651, ELM",,cBioPortal,prad_su2c_2019,Prostate Adenocarcinoma,"hg19,16:3711988-3711988","hg19,16:g.3711988C>G",0.120,,,0.0000373044624427,
690,648,H,,,,,,,,,,,s,"PCSK cleavage site, 647-651, ELM",,,,,,,,,,,
691,649,A,V,,,,,,,,,,s,"PCSK cleavage site, 647-651, ELM",,"cBioPortal,COSMIC","gbm_mayo_pdx_sarkaria_2019, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Endometrial Carcinoma, Glioblastoma Multiforme","hg19,16:3708861-3708861, hg38,16:3658860-3658860","hg19,16:g.3708861G>A, hg38,16:g.3658860G>A",0.039,endometrium,"carcinoma, endometrioid_carcinoma",0.0006093481169948,0.0006051726334565
692,650,L,,,,,,,,,,,s,"PCSK cleavage site, 647-651, ELM",,,,,,,,,,,
693,651,I,,,,,,,,,,,s,"PCSK cleavage site, 647-651, ELM",,,,,,,,,,,
694,652,K,,,,,,,Ac,,,,s,,,,,,,,,,,,
695,653,K,,,,,,,,,,,s,,,,,,,,,,,,
696,654,L,,,,,,,,,,,s,,,,,,,,,,,,
697,655,N,,,,,,,,,,,s,,,,,,,,,,,,
698,656,Q,,,,,,,,,,,s,,,,,,,,,,,,
699,657,L,,,,,,,,,,,s,,,,,,,,,,,,
700,658,R,C,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 658-662, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, cesc_tcga, cesc_tcga_pan_can_atlas_2018, coad_cptac_2019, coadread_tcga_pan_can_atlas_2018","Cervical Squamous Cell Carcinoma, Colon Adenocarcinoma, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:3708835-3708835, hg38,16:3658834-3658834","hg19,16:g.3708835G>A, hg38,16:g.3658834G>A",0.194,"cervix, large_intestine, caecum","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",0.0000318732718710,0.0000318613394507
701,658,R,H,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 658-662, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,16:3708834-3708834","hg19,16:g.3708834C>T",0.131,,,0.0000478083839969,0.0000318593092902
702,659,A,T,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 658-662, ELM",,"cBioPortal,COSMIC","ccle_broad_2019, coadread_tcga_pan_can_atlas_2018","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,16:3708832-3708832, hg38,16:3658831-3658831","hg19,16:g.3708832C>T, hg38,16:g.3658831C>T",0.154,"large_intestine, large_intestine, colon","carcinoma, adenocarcinoma",0.0000278991167937,0.0000318552497452
703,660,S,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 658-662, ELM",,,,,,,,,,,
704,661,E,K,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 658-662, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,16:3708826-3708826, hg38,16:3658825-3658825","hg19,16:g.3708826C>T, hg38,16:g.3658825C>T",0.132,endometrium,"carcinoma, endometrioid_carcinoma",0.0000199327071806,
705,661,E,Q,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 658-662, ELM",,COSMIC,,,"hg38,16:3658825-3658825","hg38,16:g.3658825C>G",0.071,"central_nervous_system, medulla","primitive_neuroectodermal_tumour-medulloblastoma, classic",,
706,662,P,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 658-662, ELM",,,,,,,,,,,
707,663,G,R,,,,,,,,,,s,"Nuclear receptor box, 663-669, ELM",,cBioPortal,"brca_mbcproject_2022, brca_mbcproject_wagle_2017",Invasive Breast Carcinoma,"hg19,16:3708820-3708820","hg19,16:g.3708820C>G",0.243,,,,
708,664,L,,,,,,,,,,,s,"Nuclear receptor box, 663-669, ELM",,,,,,,,,,,
709,665,A,,,,,,,,,,,s,"Nuclear receptor box, 663-669, ELM",,,,,,,,,,,
710,666,Q,,,,,,,,,,,s,"Nuclear receptor box, 663-669, ELM",,,,,,,,,,,
711,667,L,,,,,,,,,,,s,"Nuclear receptor box, 663-669, ELM",,,,,,,,,,,
712,668,L,,,,,,,,,,,s,"Nuclear receptor box, 663-669, ELM",,,,,,,,,,,
713,669,V,L,,,,,,,,,,s,"Nuclear receptor box, 663-669, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,16:3708802-3708802","hg19,16:g.3708802C>A",0.117,,,,
714,670,D,,,,,,,,,,,s,,,,,,,,,,,,
715,671,Q,H,,,,,,,,,,s,,,"cBioPortal,COSMIC",paad_utsw_2015,Pancreatic Adenocarcinoma,"hg19,16:3708794-3708794, hg38,16:3658793-3658793","hg19,16:g.3708794C>G, hg38,16:g.3658793C>G",0.411,pancreas,"carcinoma, ductal_carcinoma",0.0000159923236846,
716,672,I,,,,,,,,,,,s,,,,,,,,,,,,
717,673,Y,,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 673-676, ELM|Phosphotyrosine ligands bound by SH2 domains, 673-676, ELM|Phosphotyrosine ligands bound by SH2 domains, 673-677, ELM",,,,,,,,,,,
718,674,E,,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 673-676, ELM|Phosphotyrosine ligands bound by SH2 domains, 673-676, ELM|Phosphotyrosine ligands bound by SH2 domains, 673-677, ELM",,,,,,,,,,,
719,675,N,,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 673-676, ELM|Phosphotyrosine ligands bound by SH2 domains, 673-676, ELM|Phosphotyrosine ligands bound by SH2 domains, 673-677, ELM",,,,,,,,,,,
720,676,A,T,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 673-676, ELM|Phosphotyrosine ligands bound by SH2 domains, 673-676, ELM|Phosphotyrosine ligands bound by SH2 domains, 673-677, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,16:3708219-3708219, hg38,16:3658218-3658218","hg19,16:g.3708219C>T, hg38,16:g.3658218C>T",0.540,large_intestine,"carcinoma, adenocarcinoma",0.0000596729920038,
721,677,M,V,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 673-677, ELM",,COSMIC,,,"hg38,16:3658215-3658215","hg38,16:g.3658215T>C",0.370,large_intestine,"carcinoma, adenocarcinoma",,
722,678,I,,,,,,,,,,,s,,,,,,,,,,,,
723,679,A,,,,,,,,,,,s,,,,,,,,,,,,
724,680,A,,,,,,,,,,,s,"SH3 ligand, 680-686, ELM",,,,,,,,,,,
725,681,G,,,,,,,,,,,s,"SH3 ligand, 680-686, ELM",,,,,,,,,,,
726,682,L,,,,,,,,,,,s,"SH3 ligand, 680-686, ELM",,,,,,,,,,,
727,683,V,A,,,,,,,,,,s,"SH3 ligand, 680-686, ELM",,COSMIC,,,"hg38,16:3658196-3658196","hg38,16:g.3658196A>G",0.136,lung,"carcinoma, carcinoma, squamous_cell_carcinoma",,
728,684,D,,,,,,,,,,,s,"SH3 ligand, 680-686, ELM",,,,,,,,,,,
729,685,D,,,,,,,,,,,s,"SH3 ligand, 680-686, ELM",,,,,,,,,,,
730,686,P,,,,,,,,,,,s,"SH3 ligand, 680-686, ELM",,,,,,,,,,,
731,687,R,,,,,,,,,,,s,,,,,,,,,,,,
732,688,A,,,,,,,,,,,s,,,,,,,,,,,,
733,689,M,,,,,,,,,,,s,,,,,,,,,,,,
734,690,V,,,,,,,,,,,s,,,,,,,,,,,,
735,691,G,,,,,,,,,,,s,,,,,,,,,,,,
736,692,R,H,,,,,,,,,,s,"Nuclear receptor box, 692-698, ELM",,"cBioPortal,COSMIC",sclc_cancercell_gardner_2017,Small Cell Lung Cancer,"hg19,16:3708170-3708170, hg38,16:3658169-3658169","hg19,16:g.3708170C>T, hg38,16:g.3658169C>T",0.166,"biliary_tract, bile_duct",carcinoma,0.0291058967687521,0.0286461656246013
737,693,L,,,,,,,,,,,s,"Nuclear receptor box, 692-698, ELM",,,,,,,,,,,
738,694,N,,,,,,,,,,,s,"Nuclear receptor box, 692-698, ELM",,,,,,,,,,,
739,695,E,,,,,,,,,,,s,"Nuclear receptor box, 692-698, ELM",,,,,,,,,,,
740,696,L,,,,,,,,,,,s,"Nuclear receptor box, 692-698, ELM",,,,,,,,,,,
741,697,L,,,,,,,,,,,s,"Nuclear receptor box, 692-698, ELM",,,,,,,,,,,
742,698,V,,,,,,,,,,,s,"Nuclear receptor box, 692-698, ELM",,,,,,,,,,,
743,699,K,,,,Ubq,,,,,,,s,,,,,,,,,,,,
744,700,A,,,,,,,,,,,s,,,,,,,,,,,,
745,701,L,,,,,,,,,,,s,,,,,,,,,,,,
746,702,E,,,,,,,,,,,s,,,,,,,,,,,,
747,703,R,,,,,,,,,,,s,,,,,,,,,,,,
748,704,H,Y,,,,,,,,,,s,,,COSMIC,,,"hg38,16:3658134-3658134","hg38,16:g.3658134G>A",0.073,stomach,carcinoma,,
